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I. Introduction
Worldwide drug use continues to increase despite international efforts

to control demand and consumption. The United Nations (UN) estimates that
over 3% of the world’s population consumes drugs on an annual basis (UN

CHRON 1998). The United Nations International Drug Control Programme

(UNDCP) (1997) defines the term "drug" as all psychoactive substances that,
when taken into a living organism, may modify its perception, mood, cognition,
behavior or motor function. UN Secretary-General Kofi Annan (1998) has

referred to the world’s drug problem as the "contemporary plague".
The international treaties of the 1960’s and 1970’s relied primarily upon

supply side measures to reduce drug use. Supply side measures mainly
consist of punitive measures employed to reduce the production of drugs, stop

the smuggling of drugs across international borders, police intervention to

prevent the distribution of drugs and strategies designed to subvert
underground business activities associated with drugs. Recently however,
demand side (harm reduction) measures have been receiving more attention.

Demand side (harm reduction) measures run the gamut from drug use
prevention to treatment, rehabilitation and maintenance. Proponents of

demand reduction point out drugs can be grown virtually anywhere, synthetic
substitutes are readily available and there are many trade routes for drug

smuggling (Weiner 1999). As long as there is a demand for illegal drugs and

buyers willing to pay prices in excess of production costs, government
intervention on the supply side cannot succeed (Tanner 1991). Still, most

countries devote more funds to reducing supply rather than demand

(UNDCP

1997). The drug policies of most countries seek to conform to the
international legal framework for the control of illegal drugs. Many

governments fear that a shift in emphasis to demand reduction will be
perceived by the public as "giving up" in the fight against drug abuse. With the

prevailing view in many countries that drug abuse is a choice that should be
punished, lawmakers are concerned with being seen as too liberal, or perhaps

even promoting drug abuse.

However, the supply side approach has little to show for it. Despite
stiffened penalties for drug use under the 1998 Russian Law on Narcotics and

Psychotropic Substances, drug abuse has been rising at an alarming rate

(Table 1). There was an estimated 91,000 drug users in treatment in Russia
in 1994. At the beginning of 2001, there were 412,000 drug users registered
with the Ministry of Health of the Russian Federation. Actual drug use is

estimated to be ten times higher, upwards of 3 million, a 50% increase over

2000 estimates (INC 2002). An equally rapid rise in the number of HIV
infections has mirrored the increase in drug use (Table 2). Some 50- 60% of

all reported HIV infections were transmitted through injection drug use (IDU)

(EuroHIV 2003).
Table 1" Number of drug users registered with the Ministry of Health, Russian
Federation, 1994- 2001.

1996
Number

91,000

249,000

1997

1998

1999

2000

2001

2002

350,000 379,000 398,000 412,000 496,000 3,000,000*
International Narcotics Control Report, (2001)(2002)
Estimate of actual drug users from the Russian Ministry of Interior (MVD)(2002)
149,000

Recent epidemiological data points to a dramatic increase in the
incidence of HIV infections in the northwestern region of Russia. Murmansk,

a northern county near the Barents Sea, has seen the number of newly
diagnosed HIV infections increase seven-fold from 70 to 472 cases between

2000 and 2001. The HIV infection rate (51 per 100,000 population) is
approaching that of metropolitan areas such as Saint Petersburg (241 per
100,000 population and Kaliningrad (0.41% infection rate). This recent
outbreak has been fueled primarily by injection drug use (IDU), with 92% of

cases transmitted through unsafe drug-injection practices (JAMA 2002). A
high seroprevalence of both hepatitis B and C among injection drug users
indicates that the sharing of needles and syringes is a common practice

(Aavitsland 2001 ).
Table 2- HIV infections, newly diagnosed and rates per million in the Russian
Federation, 1995- 2002 (mid-year).

YEAR
Number

Rate

1995
197
1.3

1996
1,524
10.3

1997
4,377
29.7

1998
4,062
27.7

1999

2000

2001

19,851
135.8

59,281
407.5

87,177
602.6

2002
(Jan-June)

Cumulative
Total

28,746

207,711

NA

European centre for the Epidemiological Monitoring of AIDS, 2003

This recent trend has led to concern that the unfolding epidemic will

spread not only to surrounding areas of Russia, such as Arkhangelsk and the
Republic of Karelia, but to the nearby countries of Finland and Norway.

Although the rate of newly diagnosed HIV infections in Finland (2.5 per
100,000 population) and Norway (3.5 per 100,000 population) are relatively
low, the fear is that these countries could see a major spike in new cases

transmitted by injection drug users and sex workers coming across the border

(JAMA 2002).
Investigators have noted that the Norwegian-Russian border [may be]
the international border with the highest HIV rate gradient in the world.

Researchers fear that, "In the future, the epidemic may spread by sex to the

larger heterosexual population and vertically through newborns. Immediate
preventive measures are needed to save young Russians from this grave
infection" (JAMA 2002).
This paper will compare and contrast injection drug use, the legal

approach to drug use, including demand and harm reduction strategies, and
public health interventions in the Russian Federation versus the bordering
Scandinavian countries of Finland and Norway. It will also examine the

relationship between the legal and public health approach to drug use and the
incidence of HIV/AIDS and related diseases in these countries and suggest

possible policy changes which might help to quell the spread of these
infectious diseases. This paper will find that the supply side measures utilized

by the Russian Federation have done little to control drug abuse, and may
even contribute to the harms associated with injection drug use. Conversely,
the harm reduction strategies incorporated in the demand side approach

favored by Finland and Norway have helped to maintain a relatively low

prevalence of injection drug use and related harms.

II. International Law
A. A Historical Perspective
On July 28, 1958 the Economic and Social Council of the United
Nations convened for the purpose of adopting a single convention of narcotic

drugs which would replace the existing multilateral treaties in the field. This
Council represented a single instrument which would function as a form of

enforceable international law concerned with the control of narcotic drugs and
make provision for the control of raw material production for narcotic drugs. It

was the hope of the seventy-three member states represented at the original
1961 Convention to produce a multilateral treaty which would ultimately

replace all existing multilateral agreements in the drug field. Subsequently,

amendments made to the 1961 Convention in 1971, 1972 and 1988 have
been signed by 71, 97 and 106 countries respectively.

Therefore, international treaties designed to control the supply and

demand of psychoactive drugs fall primarily under the 1961 Single Convention

on Narcotic Drugs (1961 Convention), the 1972 Protocol amendment to the
1961 Convention (1972 Protocol), the 1971 Convention on Psychotropic

Substances (1971 Convention) and the 1988 United Nations Convention

against Illicit Traffic in Narcotic Drugs and Psychotropic Substances (1988

Convention). Since 1988, the UN General Assembly has issued many
resolutions, declarations and plans of action regarding drug policy. However,

while these resolutions and declarations establish standards, they do not

contain the legal authority of international agreements (Weiner 1999).

i. 1961 Convention: The provisions mentioned in the 1961 Convention focus

primarily on supply side measures. Rexed et al. (1984) note that although the
1961 Convention contains provisions regarding drug demand reduction,
details on the institutions, establishments and methodologies to be utilized are

woefully neglected. The 1961 Convention (1961) established schedules of

drugs it regulates and a mandate for treatment based on their classification

(Tables 3-6).

For example, participants in the Convention were to establish legislative
and administrative measures "to limit exclusively to medical and scientific

purposes the production, manufacture, export, import, distribution of, trade in,
use and possession of drugs" in schedule (Table 3), which includes, but is

not limited to, cannabis, cocaine, LSD and opiates (1961 Convention). The
Convention (1961) stipulates that offenses are to be punished, subject to a

Party’s constitution, by a "deprivation of liberty" and are to be imposed for
"serious offenses".
Table 3: Drugs classified as "Schedule I" under the 1961 Single Convention:

Acetyl-alpha

Acetylmethadol

Alfentanil

methylfentanyl
Alphacetylmethadol

Allylprodine
Alpha -methylfentanyl Alpha
methylthiofentanyl

Alphameprodine

AIphamethadol

Alphaprodine

Anileridine

Benzethidine

Benzylmorphine

Betacetylmethadol

Beta
hydroxyfentanyl

Beta -hydroxyl-3methylfentanyl

Betameprodine

Betamethadol

Betaprodine

Bezitramide

Clonitazene

Coca leaf

Cocaine

Cannabis and cannabis
resin
Codoxime

Desomorphine

Dextromoramide

Diampromide

Dihydrom0rphine
Dioxaphetyl butyrate

Dimenoxadol

Concentrate of
poppy straw
Diethylthiambutene
Dimepheptanol
Dipipanone

Acetomorphine

Diphenoxylate

Difenoxin

Dimethylthiambutene
Drotebanol

Eth yl m eth ylth iam butene Etonitazene
Furethidine
Fentanyl
Hydrocodone
Hydromorphone
Hydromorphinol
Isomethadone
Ketobemidone
Leveomethorphan
Metazocine
Levophenacylmorphan Leveorphanol
Ecgonine

Etorphine

Etoxeridine

Heroin

Methadone
intermediate

Morpheridine

Morphine

Levomoramide
Methadone
Morphine
methobromide

Morphine-N -oxide
Noracymethadol
Norpipanone
Para -fluorofentanyl

MPPP
Norlevorphanol
Opium
PEPAP

Myrophine

Hydroxypethidine

Mormethadone

Nicomorphine
Normorphine

Oxycodone

Oxymorphone

Pethidine

Pehtidine Intermediate

Pethindine Intermediate

Phenadoxone

Pethidine
Intemediate A
Phenampromide

B

C
Phenamorphan
Racemorphan

Pheneoperidine

Racemethorphan

Phenazocine
Racemoramide
Thebain

Thiofentan/I

Sufentanil
Thebacon
Tilidine
Trimeperidine
(1961 Single Convention on Narcotic Drugs)

The Convention (1961) classifies drugs with more common medical

purposes such as codeine, morphine, amphetamines and mescaline as
schedule II drugs (Table 4). These drugs provide a smaller risk of abuse and

therefore require less strict controls (Rexed et al. 1984). Although controlled

as in schedule II drugs, international trade in schedule III drugs suffers from
fewer restrictions (Table 5). Schedule IV (Table 6), which includes drugs such

as heroin with" particularly dangerous properties but very limited therapeutic

use" are included in schedule (1961 Convention).
Table 4: Drugs classified as "Schedule I1" under the 1961 Convention:

Acetyldihydrocodeine
Dextropropoxyphene
Ethylmorphine
Nicodicodine
Pholcodine

Codeine

Dihydrocodeine
Nicocodine
Norcodeine

Propiram
(1961 Single Convention on narcotic Drugs)

Table 5: Drugs classified as "Schedule II1" under the 1961 Convention:

Acetyldihydrocodeine
Dihydrocodeine

Codeine

Nicodicodine
Pholcodine

Norcodeine

Ethylmorphine
(1961 Single Convention on narcotic Drugs)

Table 6" Drugs classified as "Schedule 4" under the 1961 Convention"

Acetorphine
Alpha -methylthiofentanyl

Ac.e.tyl-alpha -methylfentanyl
Beta -hydroxy-3-

Alpha -methylfentanyl
Beta -hydroxyfentanyl

methylfentanyl
Cannabis and Cannabis resin
Heroin
3-m eth ylth iofe nta n yl

PEPAP

Desomorphine
Ketobemidone

MPPP
Thiofentanyl

Etorphine
3-methylfentanyl
Para -fluorofentanyl
(1961 Single Convention on narcotic Drugs)

As Rexed et al. (1984) states, signatories to the 1961 Convention are
required to "adopt appropriate legislation, introduce necessary administrative

and enforcement measures and cooperate with the international drug control

organs, as well as other countries" in order to comply with the established
international legal framework. The 1961 Convention clearly delineated how

governments were to control the supply of drugs based upon scheduling, how
criminal laws should address drug-related offenses and the information

signatories must supply to the International Narcotics Control Board (INCB).

However, the treaty does not promote standards for demand reduction
(Weiner 1999). The lone reference to demand reduction may be found in
article 38, which states:

1. The parties shall give special attention to the provision of facilities
for the medical treatment, care and rehabilitation of drug addicts.
2. If a party has a serious problem of drug addiction and its economic
resources permit, it is desirable that it establish adequate facilities
for the effective treatment of drug addicts (1961 Convention).
While the Convention (1961) addressed the desire to treat drug addicts, it

failed to address prevention. Additionally, the Convention did not provide a

policy which participants could easily implement nor did it define the role of
international instruments in developing demand reduction initiatives. In

addition, any existing provisions relating to demand reduction would have

been superceded by the 1961 Convention (Weiner 1999).
ii. 1971 Convention and the 1972 Protocol Amendment: Rexed et al.

(1984) points out that none of the international treaties specifically address
demand reduction by UN member states. Article 38 of the 1961 Convention

was amended by article 15 of the 1972 Protocol, changing its title to

"Measures Against the Abuse of Drugs" and the text to"
1)

The Parties shall give special attention to and take all practical
measures for the prevention of abuse of drugs and for the early
identification, treatment, education, after-care, rehabilitation and
social reintegration of the persons involved and shall coordinate
their efforts to these ends.
The Parties shaft as far as possible promote the training of
personnel in the treatment, after-care, rehabilitation and social
reintegration of abusers of drugs.

The Parties shaft take all practical measures to assist persons
whose work so requires to gain an understanding of the
problems of abuse of drugs and of its prevention, and shaft also
promote such understanding among the general public if there is
a risk that abuse of drugs will become widespread.
(1972 Protocol)
The Protocol (1972) further modified article 38 of the 1961Convention

by adding a provision which encouraged member states to promote regional

centers for scientific research and education and to allow parties to treat drug
abuse offenders either in addition to or in place of punitive measures. Despite
these modifications, neither the 1972 Protocol or the 1971 Convention
identified exactly who would take an active role in developing these programs

nor the methods to carry them out (WHO 1984).

10

iii. WHO" Demand Reduction" The lack of specifics found in the 1961 and

1971 Conventions and the 1972 Protocol led the WHO to identify goals for

demand reduction programs. In 1980, the thirty-third World Health Assembly
assigned the role of designing demand reduction models for preventing drug
abuse, and treating and rehabilitating drug abusers to the World Health

Organization (WHO) and various UN bodies (Rexed et al. 1984). The WHO

promptly began a study on the implementation of the 1961 and 1972
Conventions in developing countries (Wiener 1999). Information obtained

from host governments, health agencies, research facilities, areas of

commerce and law enforcement was used to compile the WHO publication,
Guidelines for the Control of Narcotic and Psychotropic Substances: In the

Context of International Treaties (WHO 1984). The WHO approach was
based on the concept that there are numerous reasons for drug use and it

may be "unrealistic" to prevent all non-medical use. The WHO focused on
prevention by way of harm reduction, the "limitation of the more individually
and socially harmful effects of drug use" (WHO 1984). Harm reduction

programs should consist of primary prevention (preventing nonusers from
experimenting and occasional users from becoming chronic users), and

secondary and tertiary measures (prevention or reduction of the number and
severity of problems associated with non-medical use) and (preventing the

worst effects of chronic drug abuse by means of treatment and rehabilitation)

(WHO 1984).

11

The WHO approach supports dissemination of information about drugs
but emphasizes accuracy in that it must be consistent with pharmaceutical

knowledge and the experience of users. The WHO discourages the use of

"scare" tactics, instead, supporting the integration of drug education into
traditional disciplines of learning. WHO guidelines emphasize the local

community as a mechanism to prevent the chronic use of drugs and to reduce
the problems associated with non-medical use (Wiener 1999).
iv. 1(388 Convention: The 1988 Convention incorporated many of the WHO

guidelines for the control of psychoactive drugs. Article 14 of the 1988
Convention specifically recommends the adoption of the demand reduction

measures outlined in the Comprehensive Multidisciplinary Outline of Future
Activities in Drug Abuse Control (CMO) (UN 1987).

The inclusion of the CMO is noteworthy as two of its four sections
contain demand side measures, a significant departure from the Conventions

of the 60’s and 70’s. In addition, the CMO actually defined objectives,
methods and key players as components of demand reduction programs

(Wiener 1999).
The CMO was adopted in 1987 during the International Conference on

Drug Abuse and Illicit Trafficking. It established measures for reducing the
demand, supply and illegal trafficking in drugs along with mechanisms for

providing treatment and rehabilitation to drug abusers. The CMO

acknowledges the role of the WHO in providing policy guidance for treating
addicts (Wiener 1999).

12

v. 1990 General Assembly: The General Assembly (1990) continued to

support demand reduction measures in its Political Declaration and Global

Programme of Action (1990 Program), citing 1991

2000 to be the United

Nations "Decade Against Drug Abuse". The Global Programme of Action

(1990) acknowledges an increasing demand for narcotic drugs and
psychotropic substances and that there are social causes "at the root of the

[drug] problem". The 1990 Program emphasizes the "treatment, rehabilitation
and occupational reintegration of former drug addicts" to reduce the demand

for illicit drugs rather than the prevention of initial use (1990 Program). This

approach is in line with the WHO position that the prevention of initial use will

not stop the non-medical use of drugs and that prevention programs should

target the reduction of the harmful effects of drug abuse in current users
(Wiener 1999).
vi. Analysis of International Law from 1958- 1990" There are clear

philosophical differences between the WHO and CMO approaches. The WHO

acknowledges that there will always be some level of drug abuse and
emphasizes harm reduction, the ultimate goal of the CMO appears to be the
creation of a drug-free world (Rexed et al. 1984). In its discussion of demand
reduction, the WHO includes measures aimed at nonusers, casual users and

chronic users alike. By contrast, the CMO focuses primarily on the prevention

of initial use and the rehabilitation of addicts. The CMO devotes scant
attention to the levels between abstinence and addiction (Dennis 1991).

13

Additionally, the WHO approach is primarily concerned with the medical
and social consequences of drug abuse while the CMO adopts a somewhat
moralistic tone. The CMO advocates national drug testing and urges the
media to refrain from glamorizing or advocating the legalization of drugs. It

sees demand and supply reduction as "banishing an acknowledged evil" and
"rescuing human beings from a precarious situation". On the other hand, the

WHO charges the media with simply providing accurate information so that
users and nonusers alike may make informed decisions (Wiener 1999).

However, despite mounting data supporting the effectiveness of harm
reduction in reducing drug-related harms and the prevention of the spread of

HIV, it still faces significant opposition. Politicians call for punitive measures
for drug users citing harm reduction measures as "too liberal". Physicians
often oppose methadone and other substitution therapy programs as not "real"

drug treatment. Law enforcement agencies feel needle exchange programs
undermine the social order. Anecdotal reports from drug users claim needle

exchange programs, especially mobile services, interfere with police efforts to
harass and arrest drug users. Negative media campaigns often focus on the

provision of clean needles and syringes to "hopeless junkies". Many

neighborhood groups openly oppose needle exchange programs in their
communities. All of these factors reinforce the general perception that HIV

positive injection drug users are somehow "guilty" as in responsible for their

own infections and as "dangerous carriers of disease" who should be avoided

(OSI 1999).

14

Thus, over the course of thirty years, the international community has
shifted, at least in theory, from a primarily supply side to a demand reduction

approach to drug abuse. The UN member states have developed a
framework for demand reduction policies and through a multidisciplinary
network of UN bodies to implement drug abuse programs (Wiener 1999).

However, this apparent paradigm shift has yet to be put into practice, as the
majority of countries still overweight their drug control funding towards supply
side measures. For example, in 1995, the countries of Pakistan and Columbia

devoted 30% and less than 1% respectively of drug control funding to drug

treatment and rehabilitation. In its 1993 and 1994 budgets, the United
Kingdom earmarked 31% of funding towards demand side measures (UNDCP

2001). In its fiscal year 2002 budget, the United States appropriated 54.6% of
its drug control monies towards supply side measures with 45.4% devoted to

demand reduction (ONDCP 2003).

B. A Current Perspective
i. The Law"

In June, 1998, the tenth anniversary of the United Nations

Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic

Substances, the United Nations General Assembly held a special session
devoted to dealing with the world drug problem (UN Chron 1998). At the close
of the session, representatives from 150 countries adopted a Political
Declaration, the Declaration on the Guiding Principles of Drug Demand

Reduction and Measures to Enhance International Cooperation to Counter the

World Drug Problem. UN member states, in recognizing that drug demand
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reduction is "an indispensable pillar in the global approach to countering the

world drug problem together’, established 2003 as the "target date for new or

enhanced drug demand reduction strategies and programmes set up in close
collaboration with public health, social welfare and law enforcement
authorities" and committed "to achieving significant and measurable results in

the field of demand reduction by the year 2008" (Wiener 1999).
ii. Analysis and Recommendations" While the United Nations claims to

have made significant strides toward demand reduction, independent

observers have questioned what exactly was achieved at the Drug Summit.
Those outside of the UN characterize the Declarations of the Summit as

simply a restatement of principles outlined in the CMO with continued priority
given to supply side measures (Wiener 1999).

However, there are notable differences in the approach used in the

Drug Summit from the declarations made at the CMO. The Drug Summit
clearly outlines the preventive measures to be included in demand reduction

programs and combines them with treatment and rehabilitation measures
under the heading of harm reduction

rUN Chron 1998).

In the wake of the 1998 Drug Summit, it is clear that the international
community must formulate a drug policy short on rhetoric and long on

workable solutions. Through its adoption of the Demand Reduction
Declaration, the UN has identified supply and demand as the two-headed

monster of drug abuse. The question is how best to allocate funds to facilitate
both supply and demand reduction.
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The Political Declaration of the Drug Summit would seem to reaffirm the
member states unwavering determination and commitment to overcoming the
world drug problem through domestic and international strategies to reduce

both the illicit supply of and demand for drugs. The Demand Reduction
Declaration calls for members "to intensify efforts in demand reduction and to

provide resources towards that end" (CND 1998). However, this intensity is

often attenuated when the participants arrive back on home soil. Many
signatories stand to profit either directly from the multi-billion dollar drug

industry or through the corruption of highly placed officials (Wiener 1999).

If supply and demand are truly addressed as equals they must receive
equal funding, with governments encouraged to gradually increase the funding
of demand side measures. This would allow for the evaluation of existing

supply side measures while gradually increasing the funding for the
establishment of demand side prevention and treatment programs (Wiener

1999).
In addition to funding, the UNDCP must develop specific strategies for
demand reduction so as not to repeat ineffective policies. The UNDCP’s
position holds that public information campaigns and school-based prevention

programs do not work. The WHO Guidelines and the Demand Reduction
Declaration of 1998 both point out the underlying socioeconomic conditions
which trigger drug use (Rexed et al. 1984). Primary prevention measures

banking on the spirit that potential users would not abuse drugs if they knew
the potential harm caused will be ineffective "if they fall on the deaf ears of
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people who believe that there is no opportunity cost for their drug abuse"

(Wiener 1999).

A key component of the Demand Reduction Declaration was the
inclusion of prevention, treatment and rehabilitation under the umbrella of

demand reduction (CND 1998). However, this distinction will be meaningless
unless policy includes users and nonusers alike (Wiener 1999). While the
effectiveness of prevention programs aimed at nonusers remains

controversial, the efficacy of treatment begins to mount (Elliot 1995).

Additionally, a recent ONDCP study states that it is not only possible to reduce
the harm associated with drugs but that it is also cost effective to do so. The

study found "that $1 spent on treatment decreases drug use as much as $7

spent on domestic law enforcement, $11 on confiscating drugs at the border
and $23 to stop drugs at their country of origin" (Shavelson 1998). If further
studies support the cost effectiveness of demand reduction programs along
with the success of treatment in reducing the harms of drug abuse it is clear

the international focus must move from supply to the demand side of illicit

drugs (Wiener 1999).
The following sections will cover drug-related laws and actual

practice in the bordering countries of Russia (Table 7), Finland (Table 8) and

Norway (Table 9), which have utilized distinctly different approaches to the
control of drug abuse and related harms. Finland and Norway have embraced
the concept of demand reduction within the framework of social welfare and

health, while the Russian Federation has focused their limited resources on

supply side measures. Current laws related to drug possession, drug
trafficking and the right to drug treatment will be addressed followed by an
overview of the criminal justice system in each country.

III. National Strategies to Control Narcotics
A. Russian Federation
Russia is party to the 1988 UN Drug Convention, the 1961 UN Single

Convention on Narcotic Drugs, the 1972 Protocol amending the Single
Convention and the 1971 UN Convention on Psychotropic Substances. The

Russian Border Service established an agreement in 1995 with Kyrgyzstan

and Tajikistan which reinforces trilateral counter-narcotics cooperation on
Russia’s borders with Afghanistan, Pakistan and Iran. Russia is also party to

the 1992 Kiev Treaty on Cooperation in Interregional Drug Investigations and

has signed the UN Convention against Transnational Organized Crime, the

Protocol to Prevent, Suppress and Punish Trafficking in Persons and the
Protocol against the Smuggling of Migrants (INC 2002).
The Russian Constitution of 1993 included an overhaul of the criminal

code, which included laws pertaining to the possession, sale, production and
trafficking of drugs. It also included the right of defendants to demand a jury
trial along with other "Western-style" rights. However, many of these laws

have yet to be put into practice as Russia struggles to convert to a system of
trial by jury (Wines 2003). In addition, the day-to-day enforcement of law is

open to the interpretation and discretion of the court and law enforcement
officials (Table 7).
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Table 7: Current Drug-Related Law Contrasted With Actual Practice in the Russian
Federation

Current Drug-Related Law

Current Practice

Article 228 of the Russian Criminal Code
prohibits the possession, sale, manufacture
or production of illicit drugs and imposes
specific penalties.

Although the criminal code does not prohibit
the non-medical use of drugs or psychotropic
substances, it does not specify what
substances are to be considered illicit drugs,
nor indicate what amounts of illicit drugs are
to be interpreted as "large" for criminal
liability. However, these gaps have largely
been filled by other legal provisions.
A draft law intended to change the criminal
code would enable authorities to arrest and
detain persons who were "high" at the time of
arrest but were no longer in possession of
any illicit drug.
Possession of drug injection equipment is
NOT illegal.

The current Russian Administration has
placed a high priority on law enforcement.
There were 59,000 heroin seizures over the
first nine months of 2000, an increase of
134% over 1999 (INC 2001).
There were 250,000 drug-related arrests in
1998, an increase from 185,000 in 1997 (INC

2001).

Police feel that drug users undermine the
social order and often harass and arrest

suspected drug users.
Low pay and difficult working conditions
continue to foster corruption among law
enforcement officials.
Needles and syringes may be purchased
legally from pharmacies without a
prescription.
Police often harass and arrest drug users
outside of pharmacies resulting in reluctance
by drug users to obtain clean needles and

syringes.
Methadone is classified as an illegal drug

Everyone shall be guaranteed the right to
qualified counsel
Imprisonment as a pre-trial detention
measure should be invoked only when there
are reasonable grounds to believe that the
suspect will hide from further investigation,
put obstacles in the way of establishing
justice or continue criminal activity.

Methadone and other substitution therapies

are precluded
Most accused persons lack the resources to
secure legal counsel.
State advocates are provided free of charge,
but the quality of representation is poor. The
bail minimum of $500 (US) is too high for the
majority of the accused, thus there is an
increase in pre-trial detainment.

A prosecutor has very broad powers, over
which the courts exercise very little influence.
A prosecutor may require pre-trial detention,
a decision not automatically reviewed by the
court.
Criminal Code of the Russian Federation, 1997
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i. Current Trends in Dru.q Use Across the Russian Federation" The

Russian Ministry of Interior reported in October 2001 that the estimated

number of drug addicts in Russia has increased by 50% since 2000 to over
three million individuals. Drug addiction among Russians 14 years of age and

under has risen 24-fold since 1991. The Russian Government now concedes
that widespread drug use among its military has become a national security

concern. The number of draftees using drugs has increased 7-fold since
1999. The government reports that 25% of officers, 40% of conscripts and

40% of soldiers of all ranks now serving in the Caucasus abuse drugs. It is
also believed that members of the military have become increasingly involved
in drug trafficking as well (INC 2002).

Officials now consider Russia to be a consumer country with heroin

trafficking and use to be a threat to the national security and public health.

Although almost half the heroin seized in 2001 was designated for export, it

appears that Russia is facing a serious drug abuse problem. Dominating all
other drug issues in Russia is the dramatic increase in the flow of heroin into
the country from Afghanistan across the southern border. In 2001, 99% of the
heroin seized in Russia came from Afghanistan, more than doubling the

amount from 1999. The sharp increase in the supply of heroin has correlated
with a sharp decrease in price, which has in turn; stimulated demand to

unprecedented levels The Taliban increased the production and export of
opium and heroin into Tajikistan, Kazakhstan and Russia in 1998 at the time of
economic recession in those countries (Waller et al 2001). The economic
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crisis resulted in a sharp drop in the standard of living in Russia, with high

unemployment rates and a decline in the funding of technical resources
available to law enforcement and treatment facilities. The widespread

availability of cheap heroin has led to significant increases in the incidence of
related infectious diseases such as HIV/AIDS, tuberculosis, hepatitis and

sexually transmitted diseases (INC 2002). According to recent reports, the
United States (US) war on Afghanistan has led the Taliban and al Qaeda to

dump their stockpiles of opium on world markets. Heroin that cost $10 (US)

per gram before the terrorist attacks on the U.S. sold for $35 (US) in
subsequent weeks and currently trades for about $15 (US). However, even at
these prices, the typical Russian heroin user cannot support a heroin addiction
without some type of criminal activity. The government now recognizes that

drugs are no longer simply an illicit product in transit (INC 2002).
While traditionally the drugs of choice in Russia have been opium

poppy straw extract and cannabis products, abuse of other drugs including
heroin, amphetamines and ephedrine are cause for concern. While the

economy is currently experiencing some growth, Russia remains a depressed
market for cocaine, which remains priced out of the Russian market. Demand

for cocaine has fallen abruptly from its peak in the more prosperous 1990’s,

although the demand for cocaine never equaled that for heroin, which is much
cheaper, more plentiful and more easily imported. LSD and
methamphetamine abuse is increasing along with the manufacture and sale of

"designer drugs" such as ecstasy (INC 2002).
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ii. Risk Behavior: There is anecdotal evidence that opiate users in Moscow

share needles and syringes more frequently than IDU’s in other regions,

primarily due to a lack of money. There is also anecdotal evidence that in
several cities, human blood is added to the drug solution during preparation as

a cleansing agent to precipitate solid particles and stabilize acidity levels. In

most cases, the person who "boils" the drug solution uses his own blood.

Assessments of HIV outbreaks in several Russian regions and cities suggest
that drug "boilers", either through negligence or ignorance of their HIV status,

might have spread the virus in this way (INC 2001)
iii. Drug Possession" Article 228 of the Russian Criminal Code:

"prohibits possession, sale, manufacture or production of illicit drugs
and imposes specific penalties. Convictions under this code involve
simple drug use as well as the sale of illicit drugs. Article 228 prohibits
the possession of illicit drugs and makes the illegal acquisition or
keeping without purpose to sell punishable by 3 years of imprisonment.
More specific punishment is provided for (3- 7 years) if possession is
coupled with intent to sell. Repeat offenders face imprisonment for 510 years."

Although Article 228 "does not prohibit the non-medical use of drugs
psychotropic substances, does not specify what substances are
considered to be illicit drugs, nor does it indicate what amounts of illicit
drugs are to be interpreted as "large" for criminal liability purposes",
these gaps are filled by other sections of the criminal law.
The Permanent Commission on Drug Control has established a list of
substances to be considered "drugs and psychotropic substances" within
Article 228. There is currently a draft law that would enable authorities to

arrest and detain persons who were "high" at the time of arrest but were no
longer in possession of any illicit drug (RusCrCode 1997).
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Possession of drug injection equipment is not illegal. Needles and

syringes may be purchased legally from pharmacies without a prescription

(RusCrCode 1997). Syringe exchanges operate, often with local resistance
from the authorities, in cities across the Federation (IHRD 2001). However,
possession of a syringe often exposes injection drug users to police
harassment or intervention by indicating illegal drug possession (DET 1999).

Syringe exchange programs run by NGO’s in cities such as Kazan, Moscow,
Saint Petersburg and Kalingrad report that it is difficult to reach injection drug

users. Many IDU’s are driven "underground" out of fear of police harassment.

Law enforcement officials often place SEP’s under surveillance. IDU’s are
confronted by police as they leave the facility and often have drugs placed on
them unless they pay protection money, which they rarely have. The result is

that DU’s are more likely to share injecting equipment thus increasing risk

factors for infection. The Russian public tolerates police corruption in this form

as they have a generally unsympathetic view of drug users. Most feel that

drug use is immoral and view drug users as criminals who belong in prison

(IHRD 2003).
The criminalization of the purchase and possession of illegal drugs
under the 1998 Drug Law has done little to discourage the growing substance

abuse problem in Russia. Court sentences continue to be light despite the

stiffening of penalties under the 1998 Law (INC 2001).
iv.

Dru Treatment" Under the Russian Constitution of 1993, Article 41,

everyone has the right to health care and medical assistance. Medical
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assistance is made available by state and municipal health care institutions to

citizens free of charge, with the money relevant to the budget, insurance

payments and other revenues (RusCon 1993). The 1998 Russian Law on
Narcotics and Psychotropic Substances provides for compulsory treatment of

drug abusers who come to the attention of the authorities. The 1998 Drug

Law restricts drug abuse treatment to government facilities (INC 2001). The
permanent Committee on Drug Control established a list of substances
considered to be "drugs and psychotropic substances" within the meaning of

Article 228 and other relevant legislation. Methadone has been classified as

an illegal drug (RusCRCode 1997). Since methadone is classified as an
illegal drug, substitution therapy is precluded (RusCrCode 1997). Opposition

to methadone maintenance and other substitution therapies on the basis that
they are not "real" drug treatment comes from many drug treatment physicians

(IHRD 1999).
v.

Dru Trafficking:

Up until 2000, neither Russian policy makers nor law

enforcement officials considered making drug trafficking a high priority. Drug

abuse was considered low and restricting the transit of narcotics through
Russia was given a lower priority than other seemingly more critical illegal
activities. However, with the dramatic rise in drug abuse, the Russian

government now considers drug trafficking a serious threat to national security

(INC 2002).
The 1998 Russian Law on Narcotics and Psychotropic Substances
stiffened penalties for the distribution and large-scale trafficking of illicit drugs
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(INC 2001). While this has done little to stem the growth in substance abuse
in Russia, the1998 Law has given law enforcement a somewhat increased

ability to deal with serious drug traffickers. Afghan heroin flows across the
southern Russian border and has increased three-fold over the past three

years. The Taliban increased the production and export of opium and heroin
into Russian in 1998 coinciding with the Russian economic crisis. The

resulting sharp drop in the standard of living for many Russians, high

unemployment rates and decreased financial and technical resources
available to law enforcement coincided with the widespread availability of

cheap heroin (INC 2002).
While Russian law enforcement budgets were increased 20% in 2001

and again in 2002, law enforcement morale is low and the temptation for

corruption remains. Equipment has deteriorated and veteran officers have

been lost to attrition. Little new funding is available for new equipment or

procurement of new technology. Thus, inadequate budgets, low salaries and
a lack of technical resources and support hamper performance and encourage
corruption. Funds for training are also extremely limited (INC 2002).
vi. Criminal Justice System in Principle and Practice: The Russian

Constitution of 1993 identified the basic human rights and liberties of its
citizens under the law. These rights include, but are not limited to: the right to

be considered innocent until proven guilty, constraints on pretrial detention,
the right to a jury trial, the right to qualified legal counsel and parameters for
the setting of bail.
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Under the Russian Constitution of 1993, Section One, Chapter 2,

Rights and Liberties of Man and Citizen, Article 17, the following rights exist:

"The basic rights and liberties in conformity with the commonly
recognized principles and norms of international law shall be
recognized and guaranteed in the Russian Federation and under this
Constitution".
Under Article 22"

"Everyone shall have the right to freedom and personal inviolability.
Arrest, detention and keeping in custody shall be allowed only by an
order of a court of law".
Under Article 45"

"State protection for human rights and liberties in the Russian
Federation shall be guaranteed".
Under Article 46"

"Everyone shall be guaranteed protection of his or her rights and
liberties in a court of law".

Under Article 47:

"No one may be denied the right to having his or her case reviewed by
the court and the judge under whose jurisdiction the case falls under by
law. Anyone charged with a crime has the right to have his or her case
reviewed by a court of law with the participation of jurors in cases
stipulated by the federal law".
Under Article 49"

"Everyone charged with a crime shall be considered not guilty until his
or her guilt has been proven in conformity with the procedures
stipulated by the federal law and established by the verdict of a court of
law. The defendant shall not be obligated to prove his or her own
innocence". "The benefit of the doubt shall be interpreted in favor of the
defendant".
Under the Criminal Processing Code, Article 89"
"Imprisonment as a pretrial detention measure should be invoked only
when there are reasonable grounds to believe that the suspect will hide
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from further investigation or court; or will put obstacles in the way of
establishing justice in the criminal case; or will continue his involvement
into criminal activity. Otherwise, the prosecutor or judge may release
the accused on bail".
Under Article 99:
"There is no amount set for bail, however, the minimum can’t be less
than $500 (US), or two to three months of the average Russian salary".
Under Article 97:
"pre-trial detainment cannot exceed two months, but a prosecutor may
extend this term to three months. For crimes of a serious nature, the
Deputy Prosecutor general may extend this term to 1 year’.
Under Article 48"

"Everyone shall be guaranteed the right to qualified legal counsel.
Legal counsel shall be provided free of charge in cases stipulated by
the federal law. Every person who has been detained, taken into
custody or charged with a crime shall have the right to legal counsel
(defense attorney) from the moment of, respectively, detention or
indictment.
(Criminal Code of the Russian Federation 1997)

The former Soviet state outlawed juries in 1917. Since that time, the

fate of accused Russians rested in the hands of a three-member panels which

served as judge, jury and often, assistants to the prosecutor. This form of

"justice" stood the test of time, producing 995 convictions for every 1,000
criminal cases as recently as 1996 (Wines 2003).

A new Code of Criminal procedure was approved by the Russian
Parliament in July 2002. The new Code brings Russia in line with international

standards of criminal justice and should facilitate integration into western legal
institutions. The overhaul of the Russian Criminal Code gives defendants

accused of capital crimes the right to demand a jury trial. Many of the judicial
reforms had been written into the 1993 Russian Constitution. However, it
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wasn’t until 1999 when Russia’s top court ordered the government to put these
reforms into practice. Still, the Russian parliament failed to consider
legislation until 2002. Even then, parliament voted to delay jury trials in 20

oblasts, including Moscow, because officials were unprepared to adopt the

changes (Wines 2003).
Thus, while judicial reform was an early priority of post-Soviet Russia,

reforms have stalled. The Judicial Reform Department was dissolved in 1995
followed by a judge’s strike. Currently, the Russian judiciary is in crisis as the

20,000 judges represent half the number required by the new system (Wines

2003). The strengthening of drug laws has led to a sharp increase in the
workload of judges, but there has been no enlargement of staff to handle the
increase. The courts are currently bankrupt, thus judges and court staff do not
receive their salaries. An experimental trial in 2002 had to be halted because

the $1.75 (US) per diem failed to attract potential jurors (Wines 2003).

Recent delays have raised the suspicions of civil liberties proponents
who fear the rights of the accused will be "watered down" (Wines 2003). A

prosecutor may require pre-trial detention in one of the countries many SIZO’s,
or pre-trial detention centers, a decision that is not automatically reviewed by
the court. The prosecutor has very broad powers, over which the courts
exercise very little influence. The bail minimum of $500 (US) is too high for

the majority of the accused. Since the minimum set for bail is so high, many
Russians cannot afford to post bail, thus there is an increase in pre-trial

detainment (Schoofs 2002).
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Most accused persons lack the resources to secure legal counsel.
State advocates are provided free of charge, but the quality of this
representation is poor (RusCrCode 1997)

The number of HIV-infected prisoners has increased dramatically in

recent years. Approximately 16% of Russia’s roughly 200,000 registered HIV
positive individuals are in prison, while many others who are currently free

having been recently incarcerated (Schoofs 2002). Although the data is
incomplete, it is estimated that the prevalence rate of HIV among prisoners

was 21.8 per 100,000 prisoners in 1996, rising to 106.5 per 100,000 prisoners
in 1997. There were 1,636 HIV-infected persons in confinement institutions in

1997. During the nine years from 1987 to 1995, 46 HIV-infected prisoners had
been identified, none of them injecting drug users. In 1996, 300 HIV-infected
individuals arrived at Russian prisons, almost 90% of them injecting drug

users. In 1997, 1,636 prison inmates were HIV-infected, 1,516 (93%)injecting

drug users. In early 1998, 468 HIV-infected prisoners arrived, including 434

(93%) injecting drug users. As of May, 1998, approximately 20% (1,732) of all
people registered as HIV-infected were in prison (DET 1999).
The highest number of HIV-infected people in prison was in Kaliningrad

(370), followed by Krasnodarsky krai, Rostovskays region (274), Tverskaya
region (201), Nizhegorodskaya region (105) and the Moscow Departments of
Interior Affairs (100). Most HIV infections are detected at the time of entry into

an investigative ward. However, in 1997, the proportion of first HIV diagnosis
decreased to about 60% (DET 1999).
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The draconian drug laws of the Russian Federation mean possession

of even small amounts of heroin for personal consumption can bring long
prison sentences. The fact that drug users are often jailed repeatedly has led

to fears that the spread of HIV/AIDS will be fueled through IDU’s moving in
and out of prison (Schoofs 2002).

Although sufficient evidence of HIV transmission in prisons is lacking,
there are anecdotal reports of sex between men, rape and injecting drug use

(DET 1999). Prison officials admit that HIV and related infectious diseases
could spread throughout the prison system unnoticed. Inmates are supposed

to receive mandatory HIV testing under the law upon entering prison. In
practice, most inmates are tested only if they appear ill. The prisons main

defense against the spread of infectious diseases appears to be segregation.

Many keep infected and uninfected prisoners in separate cellblocks. The
problem is that the HIV test measures antibodies, not the actual presence of

HIV. Since it may take an immune system up to six months to generate
antibodies against HIV, it is possible to place an infected prisoner in the

"uninfected" cellblock. This method can also lead to a false sense of security

among inmates as to who is and isn’t infected (Schoofs 2002).

Drug distribution and consumption appears to be taking place in prisons
on some level. Overcrowding has made the control of drugs and syringes

nearly impossible. Needle and syringe sharing appears to be common, and
disposable and clean equipment is usually not available (DET 1999). Bleach
is often restricted as it can be used to attempt suicide or harm other prisoners
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or guards. Condoms are rarely available as sex is not allowed (Schoofs

2002).
Despite the many problems facing the Russian criminal justice system,
the significance of putting the recent judicial reforms into practice cannot be

overstated. Drug abusers must be afforded due process, equality and human

rights under the law. A legal system which continues to discriminate against
and violate the human rights of drug users will only serve to fuel the epidemic

of drug abuse and related infectious diseases in two ways. Fear of
harassment and abuse often sends drug abusers underground and away from
the few support systems that exist. Secondly, those who fall prey to the

system will undoubtedly find themselves in a prison system which exposes
them to drugs and infectious diseases such as HIV/AIDS, tuberculosis and

hepatitis.

B. Finland
The responsibility of coordinating national drug policy in Finland is

delegated to the Ministry of Social Affairs and Health. The Ministry also
formulates narcotics legislation and regulations on the legal manufacture, sale
and use of narcotics. The Ministry of Justice is responsible for the preparation

of laws which regulate narcotics offenses and related issues (STAKES 2001).
The basis for drug control in Finland is the UN Drug Conventions.
Finland is party to the 1988 UN Drug Convention, the 1961 UN Single

Convention on Narcotic Drugs, the 1972 Protocol amending the Single
Convention and the 1971 UN Convention on Psychotropic Substances.
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Additionally, Finland has extradition treaties with several countries and ratified
the European Union’s extradition treaty in 1999. Finland has signed the UN
Convention against Transnational Crime, the Protocol to Prevent, Suppress

and Punish Trafficking in Persons and the Protocol against the Smuggling of

Migrants. Since regaining independence, Estonia has established bilateral
narcotics agreements with Finland. The United States has a mutual

assistance customs agreement with Finland and although a 1976 bilateral
extradition is in place between Finland and the United States, Finland will only
extradite non-Finnish citizens to the US. Membership in the UNDCP has

provided the majority of financial assistance to drug production and transit and
provides the basis for most of Finland’s cooperation with the United States

(INC 2002).
Based upon the 1997 memorandum of the Drug Policy Committee,

Huumausainesstrategia 1997, 56-60 (STAKES 2001), the Finnish Government
issued a resolution on drug policy in 1998 entitled the "Government decision-

in-principle on Drug Policy". The decision-in-principle outlines Finland’s basic

approach to drug policy as"
Finland’s drug policy is based on general socio-political measures,
national legislation and intemational conventions. The aim is to
intensify drug control based on a total prohibition on distribution and
use of drugs, to prevent experimenting with drugs and their use, as well
as to provide, and facilitate access to, adequate care and treatment for
drug abusers. The goal of drug policy is to prevent drug use and the
proliferation of drugs so as to make the detrimental effects on
individuals, and the costs entailed by drug abuse, and related
prevention, care and control measures, as small as possible. In its drug
policy, Finland takes account of the European Union’s lines of action
relating to drug policy and foreign and security policies.
(STAKES 2001)
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The national drug strategy proposal was completed in 1997 by the
National Drug Policy Committee. The Government Decision-In-Principle on

Drug Policy, based upon the Committee’s proposal, was published in 1998
(Table 8). The Decision outlines the Finnish approach to drug policy as"
The proliferation and use of drugs is prevented primarily by influencing
the population’s living conditions on the basis of equality and fundamental

rights, by implementing Nordic welfare policy. In this way, the factors that

expose people to drug use and intoxicant problems are reduced. Education
and information are the means to influence attitudes and to encourage young

people to lead a drug-free way of life. Drug use and its related problems and
damages can be prevented successfully by an early and efficient intervention
in young persons’ drug problems and in symptoms preceding drug use. The

educational system and social and

health services can intervene at an

early stage, if the problems and symptoms can be identified and if they can be
tackled in the right way (STAKES 2001).
The Finnish Government has since set up a drug policy coordination

group which is charged with coordinating national drug policy and to increase
collaboration between relevant authorities in an effort to implement and
monitor the drug program. The group, represented by individuals from

relevant Ministries and agencies, has prepared an action plan which was

approved by the Finnish Government on October 5, 2000 (Government
Decision-In-Principle on Drugs Policy, 2000). The overall goal of the plan is to
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reduce both the supply and demand of drugs and to retard the growth of
narcotics use and related crime

(STAKES 2001).

Current drug-related law and narcotics offences are outlined in the
Finnish Penal Code. Examples of drug law found in the penal code and the

practical realities of enforcement are contrasted in Table 8.
Table 8: Current Drug-Related Law Contrasted with Actual Practice in Finland:

Current Drug-Related Law

Current Practice

Narcotics offences are specified in the
Finnish penal Code (1304/1993) whereby
drug offences are classified as narcotics
offences, preparation of narcotics offences
and abetment of narcotics offences.
Sentences range from fines up to a maximum

An amendment to the Penal Code (654/2001)
in September 2001 implemented a system of
fines rather than jail time for the illegal usage,
possession or attempt to obtain small
amounts of drugs for personal consumption
Penalties are often a fine or not more than six
months imprisonment.
Amendment 654/2001 enables summary
penal proceedings where the prosecutor may
administer punishment outside of the court.

of two years imprisonment.
Narcotics crimes classified as aggravated

may carry sentences of one up to ten years.

Prosecution or punishment may be waived if
the offence is deemed insignificant in view of
the amount and quality of narcotics.

Substitution treatment using buprenorphine,
methadone or lavacetylmethadol is legal, as
is maintenance therapy.

Syringe exchange programs are legal.

Assignment to a drug treatment center may
be applied in lieu of prison time.
There are currently some 30 facilities offering
substitution therapy in Finland.
There are currently 13 counseling centers in
Finland who provide information on risk
factors for infectious disease and where they
may exchange their contaminated needles.

(STAKES 2001)

i. Current Trends in Drug Use Across Finland: Throughout the 1990’s,

Finnish society experienced a steady increase in drug experimentation along
with harms related to drug abuse

(STAKES 2001). Officials attributed the

increase in the experimentation with and use of drugs to societal changes

such as economic recession, unemployment and weakened social networks.

35

In addition, more frequent international contact, increased availability and use
of drugs in neighboring countries and a culture more accepting of illegal drug

use are also cited (Drug Strategy 1997). Finish police attribute the increase in
illegal drugs to the wider availability of drugs in post-cold war Europe,
diminished police resources and greater experimentation by Finnish youth

(INC 2002).
However, since the turn of the century, early indicators suggest the
rapid increase of the 1990’s may be slowing down. This reversal of trend

appears to be most marked among young adults, arguably the population
most susceptible to drug abuse. While this apparent decline is supported by
school health surveys taken from 1999 to 2001, it remains to be seen if this is

an isolated cycle or the beginning of a new trend (STAKES 2001).
The most common form of drug abuse in Finland is polydrug use which
involves the mixing of alcohol with such agents as sleeping pills, pain killers,

tranquilizers and sedatives (Drug Strategy, 1997). The rate of cannabis use in
Finland is the lowest in Europe and the use of cocaine is rare. However,
Finland has seen a steady rise in the use of amphetamines, meth-

amphetamines and heroin over the past decade, along with a significant rise in
the use of ecstasy (INC 2002). Although the majority of the Finnish population
maintain a negative attitude toward illegal drug use, the current culture is

adopting a more tolerant viewpoint (Drug Strategy, 1997).
ii. Risk Behavior: Risk behaviors associated with the spread of infectious

disease are relatively low throughout Finland. Reports of needle sharing or
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the use of human blood during the preparation of injecting drugs are rare. The

fact that drug policy is firmly imbedded in the welfare policy along with the

efforts of non-governmental organizations (NGO’s) has enabled it to become
integrated into Finnish society as a whole. Drug treatment, including the use
of methadone, along with needle-exchange programs are widely available

throughout most of the country (Drug Strategy, 1997). The infection
counseling center Vinkki is a location where used hypodermic needles may be

exchanged for new ones. The impact of the Center is illustrated in Table 9,
which shows a reduction in risk behaviors over time from 1997 to 1999. It has

been in operation in Helsinki for over three years and ten other municipalities
have opened similar centers since early 2001. Over 4500 of an estimated 10

-15,000 injection drug users visited existing centers in 2000 alone (STAKES

2001). Finland’s efforts to reduce the detrimental effects of drug use may
have helped in maintaining its relatively low levels of related infectious
diseases. Thus, a policy designed to reduce the detrimental effects of drug

use has to be considered when assessing the lack of high risk behaviors and
subsequent spread of related infectious disease in Finland.
Table 9: Impact of the Vinkki Counseling Center as to decreased risk factors associated
with injection drug use (STAKES 2001).
Behavior

1997

Has not borrowed syringes
during the month
Has lent syringes to others

55%

September 1, 1998 June
9, 1999
67%

75%

44%

Reportedly cleaned syringes
after use
Proportion of multi-risk users

46%

89%

21%

3%

37

iii. Dru_a Pos,,session" The Finnish Government released a comprehensive

policy statement on illegal drugs in 1998, which articulated a policy of

complete prohibition. The document alerted citizens of Finland that all
narcotics violations, however small, were punishable under Finnish law.
Narcotics offences are specified in the Finnish Penal Code

(1304/1993)

whereby drug offences are classified as narcotics offences, preparation of
narcotics offences and abetment of narcotics offences. Sentences range from

fines up to a maximum of two years imprisonment. Narcotics crimes classified

as aggravated narcotics offences may carry sentences of one up to ten years
of imprisonment. The criteria for aggravated drug offences includes:
The offence involves a highly dangerous substance or large
quantities thereof.
Considerable financial profit is sought.
The offender acts as a member of a group organized for the
extensive commission of such an offence.
Serious danger is caused for the life or health of several

people.
Narcotics are distributed to minors or in an otherwise

unscrupulous manner.
The narcotics offence, when assessed as a whole, is to be
(STAKES 2001)
deemed aggravated.
According to the law, a highly dangerous drug refers to a narcotic

substance which may cause death by overdose, serious damage to health

even through short-term use or severe withdrawal symptoms (STAKES 2001).
Legislation that increased the ability of law enforcement to pursue
violators with additional investigative tools, including undercover "buys" was
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passed in late 2000, going into effect in March, 2001. Wiretapping had
already been authorized in 1995.

However, in September, 2001, Finland instituted a reduction in the
penalty for simple possession. An amendment (654/2001) to the Penal Code
implemented a system of fines rather than jail time for the illegal usage,
possession or attempt to obtain small amounts of drugs for personal
consumption (INC 2002). The penalty is a fine or not more than six months’
imprisonment. This amendment enables summary penal proceedings, where
the prosecutor may administer punishment outside of the court. Preliminary

investigation is often less extensive than in normal preliminary investigations

(STAKES 2001 ).
This reform measure has helped to clarify regulations on waiving

prosecution in drug related crimes. This amendment stipulates that

prosecution or punishment may be waived if the offence is deemed

insignificant in view of the amount and quality of narcotics, the situation and
the circumstances. This may also be invoked when the suspect has sought

treatment specified by the Ministry of Social Affairs and Health. Formally, the
law stipulated that such persons had to commit themselves to treatment. In
addition, other regulations pertaining to the waiving of proceedings are also

applicable to drug offences (STAKES 2001). However, Finnish police fear this

sends the wrong message to Finnish citizens and have an established a

strategy for 2002-2003 placing increased emphasis on street-level drug
trafficking (INC 2002).
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iv.

Dru Treatment" The government of Finland has taken the view that drug

demand reduction is best reached through the implementation of an effective
Nordic welfare policy. Such policy focuses on early intervention before drug

use becomes a concern. Local government is given significant leeway in
addressing demand reduction using federal monies. Drug education is
required in all Finnish schools (INC 2002).

Drug treatment is available though limited in certain areas of the
country. The goal of the social welfare policy is to guarantee equal access
and treatment to all. The treatment of drug addicts takes place at the primary
level and above. A-Clinics and short-term treatment centers specifically

designed for younger drug abusers are found throughout Finland. Tertiary

treatment is available in the detoxification unit at the Helsinki University
hospital. Long-term treatment is available through community care,

therapeutic communities and through individual and group therapy (Drug

Strategy, 1997). All forms of drug treatment are strictly voluntary as the
mandatory treatment of drug abusers is rarely practiced. Methadone
replacement therapy is widely available although the use of buprenorphine for

drug replacement and maintenance is a relatively new practice in Finland (INC

2002).
The Ministry of Social Affairs and Health issued an Order in 1997

(28/1997) on the detoxification and substitution treatment of opioid addicts with
medicines containing buprenorphine, methadone or lavacetylmethadol. On

November 2, 1998 a new order was issued (42/1998) and on July 1, 2000 the
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Ministry of Social Affairs and Health issued a Decree on the Question

(607/2000). Previous orders had limited the length of detoxification period
preceding substitution treatment to 12 months and the number of facilities

evaluating treatment need was limited to three university hospitals. The new
decrees have limited the detoxification treatment period to one month, with
substitution as well as maintenance treatment as a new method are intended

for longer treatment. The evaluation of need for detoxification, substitution
and maintenance treatment has been expanded to include all Finnish

university and other central hospitals in addition to the Jarvenpaa Addiction
Hospital (STAKES 2001).

According to the 2000 Decree on the question, opiod addiction is
defined by the ICD-10 criteria (F11.2x). All treatment types require an
individual treatment plan which specifies all medical, pharmaceutical and

psychosocial care and follow-up required by the patient. Both detoxification

and substitution treatment are defined by the Decree as rehabilitative care

aiming at a drug-free lifestyle. New therapies are introduced in the form of
maintenance treatment with harm reduction and enhancement of the patient’s

quality of life as focal points of care. Additionally, maintenance treatment may

be used to prepare the patient for rehabilitative substitution treatment.

Commencement and follow-up of all forms of treatment are assigned initially to
the aforementioned hospitals, but treatment may be continued at a public

health care or substance abuse service unit. The Decree emphasizes the
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importance of providing long-term treatment as close to the patient as possible

(STAKE S 2001 ).
v. Dru_ Trafficking" The production, cultivation and trafficking of narcotics is
considered to be relatively modest in Finland, as is the production of precursor
chemicals. Law enforcement has thus far been effective in controlling drug

trafficking from abroad. The principal sources of illegal drugs in Finland are
Russia, Estonia, Spain and the Netherlands. Finnish legislation makes the

transport of narcotics illegal and provides for law enforcement, the extradition
of traffickers, transit cooperation and the control of precursor chemicals (INC

2002).
Finland has established a significant international effort to control drug

trafficking and related organized crime. Finnish police support four liaison
officers in Russia and four in other European cities. Finland pools its

resources and shares information with the other Nordic countries of Sweden,

Norway, Denmark and Iceland. In addition, Finland participates in multilateral
efforts through the European Union and the Council of Baltic Sea States’
organized Crime task Force (INC 2002).
vi. Criminal Justice System in Principle and Practice: The rise in drug use

over the past decade has resulted in a consequent increase in the number of

sentences for drug offenses. Approximately 15 20% of these sentences
have been conditional, with 10- 11% unconditional and 69- 75% resulting in
fines. The average length of a prison sentence for drug offenses was 27.4

months in 1994. Punishments imposed on drug traffickers have been most
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severe with sentences exceeding 12 years being imposed on principals in
such cases. The prosecution and court practice punishments have rarely

been waived with regard to drug offences. As per the Narcotics Act of 1972
and the Penal Code of 1994, the waiving of punishment is to be used only in

cases of drug use and related offences. In addition, grounds for waiving such
cases are contingent on the individual seeking drug treatment approved

through social and health authorities. The frequency of such cases being
waived has declined from some 15- 30% in the early seventies to less than

10% today (Drug Strategy, 1997).
The guiding principle behind the 1994 Narcotics Act was to address

professional and organized crime. The goal of this act was to make drug use
punishable as a means to convey a no tolerance message regarding drug use

and to provide an effective deterrent against the growing illicit drug market in
Finland (STAKES 2001).

Based upon changes made in the 1994 Penal Code, the prosecution

and sentencing of drug use and related crimes may be waived if the crime
does not undermine common obedience to the law or if the perpetrators
commit themselves to a treatment regimen which has been approved by the

Ministry of Social Affairs and Health. The provisions outlined in the 1994 Code
address the personal use, import, possession or manufacture of drugs.
Historically, it is believed that prosecutors have often waived prosecution

inappropriately, viewing court proceedings as too cumbersome for the
imposition of a simple fine. In an attempt to remedy this, the Prosecutor-
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General issued clear guidelines in January 2000 for the waiving of prosecution
in various types of drug and related crimes. According to the guidelines
issued in (5/2000), the decision to prosecute an adult should be based on the

amount and quality of the drugs in question and the duration of use. In
addition, other related circumstances may be taken into account. The point of

reference however, remains the vague concept of did the crime undermine

common obedience to the law. In the case of long-term drug users, punitive
action becomes less significant. The guidelines are applicable to both adults

and juveniles, but the defendant’s age may be taken into account, especially if
the act is deemed to have resulted from thoughtlessness or imprudent

judgment (experimental use) (STAKES 2001).

The ambiguity of drug laws in Finland was addressed by the Ministry of
Justice in late 2000 through a proposal for amendment, which was

subsequently passed in summer 2001, taking effect on September 1, 2001.
The amendment defines a "user crime", making it possible to impose a fine in

the form of summary penal judgment for the use, possession or attempt to
obtain drugs for personal use. The goal of the amendment was to replace the

abstract nature of the current law with a more precise expression of quantity,
quality, situation and/or circumstances. The reform does not make the
punishment more lenient, it simply expedites the imposition of a fine in such

cases (STAKE S 2001 ).

Court hearings in drug trials differ from other trials with respect to the
burden of proof. It is often more difficult to establish proof in drug offences
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since the evidence is generally based upon the story of the offender or an

accomplice (STAKES 2001).

C. Norway

Norway is party to the 1988 UN Drug Convention, the 1971 UN
Convention on Psychotropic Substances, the 1961 UN Single Convention on
narcotic

Drugs and the 1972 Protocol amending the Single Convention.

Norway has in place bilateral customs agreements with the United States,
Russia, select countries in Central and Eastern Europe and the European
Union. Extradition of criminals to the United States and other countries is

governed by 1975 extradition law. The UN Convention against Transnational
Organized Crime, the Protocol to Prevent, Suppress and Punish Trafficking in

Persons and the Protocol against the Smuggling of Migrants have all been
signed but not yet ratified by the Norwegian government (INC 2002).
i. Current Trends in

Dru Use Across Norway: Although illegal drug

production was considered insignificant in 2001, consumption of illicit drugs

appears to be increasing significantly (CIA 2002). Surveys among 15 20
year olds suggest a distinct increase in the number of different drugs being
abused, beginning in the late 1990’s up to the present. Seventeen percent of

young people aged 15- 20 reported the use of cannabis in 2001 compare
with less than ten percent up until the mid 90’s. Among other illegal drugs, 1

2% report the use of LSD, heroine, cocaine and ecstasy at least once.
Additional surveys suggest a substantial increase in long-term drug abuse.

The national Institute for Alcohol and Drug research shows that the number of
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injection drug users has grown to 9- 12,000 in a population of 4,459,000

(0.25%) during the late 1990’s (1998) from 4,500 in a population of 4,230,000
(0.11%) at the end of the 1980’s (1989). These surveys also show that the
majority of injection drug users inject heroine (SIRUS 2001).

Once considered a problem associated only with youth, drug abuse is
becoming a social problem increasingly among the middle-aged. The drug
abuser population has grown older and evidence suggests that this trend will
continue. Additionally, there appears to be more recruiting among older

males, possibly due to traditional alcohol abusers moving to heroin. The
overall increase in the use of heroin is a function of the increase in the number

of users along with an increase in the dosage size per injection (SIRUS 2001).
Seizures of illegal drugs rose 16% in 2001, led by cannabis (38%),

benzodiazepines (20%) and amphetamines (15%). Seizures of heroin arriving

from Central Europe also increased in 2001. Norway continues to place tight
controls on the sale, export and import of precursor chemicals (INC 2002).
ii. Risk Behavior: In 1997, a user survey was taken among clients of a

needle-exchange bus in the capital city of Oslo, considered the primary base
for injection drug use in Norway. According to the survey, 4% of injection drug

users reported the use of a second hand needle during their last injection.
The majority of these individuals reported that the previous user was a steady

drug partner. However, given the context of the survey, a certain degree of
underreporting may be assumed (SIRUS 2001).

46

iii.

Dru Possession" Norway has no separate laws that deal with drugs

only. Most illegal activities relating to drugs are covered under the Norwegian
Penal Code of May 22, 1902, with the exception of the use and possession of
minor quantities of drugs which fall under the Act on Medicinal Products of

December 4, 1992 (Table 10) (SIRUS 2001).
The use and possession of small quantities of drugs was reclassified to

a misdemeanor in 1984. The use and possession of small amounts of drugs
do not fall under section 162 of the General Civil Penal Code, but under the

more lenient Act on Medicinal Products of December 4, 1992, no. 132, section

31, paragraph 2. Punishment, which also applies to complicity, is fines or
imprisonment not to exceed 6 months (SIRUS 2001).

In an effort to discourage the use of illegal narcotics, the Norwegian
government increased the fines relating to narcotics crimes in 2000. The
maximum penalty for possession of illegal narcotics is 21 years in prison,

although penalties for the possession of small amounts are relatively mild (INC

2002).
Despite relatively strict laws pertaining to illegal drug use, punitive

measures are often mild. The possession of small quantities of drugs for

personal consumption is classified as a misdemeanor. Examples of current

drug-related law in Norway and the realties of enforcement practices most
often employed are contrasted in Table 10.
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Table 10: Current Drug-Related Law Contrasted With Actual Practice in Norway

Current Drug-Related Law

Current Practice

Norway has no separate laws which deal with
drugs only. Most illegal activities relating to
drugs fall under the Norwegian Penal Code of
May 22, 1902.
The use and possession of minor quantities
of drugs falls under the Act on Medicinal
Products of December 4, 1992
The Norwegian Government increased fines
relating to narcotics crimes in 2000. The
maximum penalty for possession of illegal
narcotics is 21 years

The use and possession of small quantities of
drugs was reclassified to a misdemeanor in
1984.
Punishment, which applies to complicity, is
fines or imprisonment not to exceed 6
months.

The penalty for intentionally manufacturing,
acquiring, importing, exporting, storing,
sending or conveying narcotic drugs includes
fines and/or imprisonment not exceeding 2

years

Penalties for the possession of small
amounts of drugs are relatively mild.

The term of 21 years is meant to address
aggravating circumstances such as largescale international drug trafficking.
Penalties for drug offenses primarily depend
upon the substance and quantity involved.
Personal consumption is shown greater
leniency than cases which were motivated by

profit.
The Prison Act of December 12, 1958 allows
for drug treatment to be substituted for prison
time.
Substitution therapy is legal using
methadone, Subutex, LAAM or high-dosage
buprenorphin.

Syringe exchange programs are legal

Transfer to a treatment facility is voluntary
Substitution therapy is administered through
a national treatment center in Oslo along with
regional coordinating agencies covering four
health regions
Clean syringes and needles are available at
supervised "needle-rooms".

(SlRUS 2001)

iv. Dru_ Treatment: Norway’s Ministry of Health and Social Affairs has

continued to implement educational programs to reduce drug abuse through

the Norwegian Directorate for the Prevention of Alcohol and Drug Problems.

Released in 2000, the counter-narcotics program, "Narcotics Problems in

Norway: Report and Anti-Drug Measures", proposed the establishment of
"needle-rooms" where supervised addicts could inject drugs. First
implemented in 2001 on a limited basis to reduce drug-related crime and the

spread of HIV, it is unknown whether this system will be maintained and
expanded (INC 2002).
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The Prison Act of December 12, 1958, No. 7, Section 12, allows for a

prison sentence to be substituted for treatment. The decision to transfer a
convicted individual to a treatment facility is made by the Governor of the
Prison Service Institution, or in the case of serious crime, the Prison Service
Administration. Special circumstances allow for the execution of a sentence

to commence in a treatment facility. Transfer to a treatment facility is

voluntary in accordance with section 12 of the Prison Act (SIRUS 2001).
v. Drug Trafficking" According to the Ministry of Health and Social Affairs
and the police, illicit drug production, trafficking and the import and export of

precursor chemicals remains insignificant in Norway due to tight legislation,
enforcement and a harsh social climate. However, Norway remains a market
for illegal drugs from Eastern and Central Europe, especially ecstasy from the

Netherlands, although an increase in drug seizures appears to be making its
mark (INC 2002).

Norway’s Customs and Excise Directorate has continued to implement
its own counter-narcotics plan which focuses on slowing drug imports and the

seizure of drug money and precursor chemicals used in drug production. A
mobile narcotics control unit has been established and surveillance and

coordination with both the police and Coast Guard has been maintained

(INC

2002).
vi. Criminal ,Justice System in Principle and Practice: The Norwegian

General Civil Penal Code and the Act on Medicinal Products fail to define the

term "drug". Section 22 of the Act on Medicinal Products empowers the King
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to determine exactly which substances shall be regarded as drugs. As of

January 1, 2001, the King delegated this responsibility to the Norwegian
medicines Agency, who has since detailed a list of narcotics (The Narcotics

List of 30, June 1978,

No.8).

The national drug list includes all psychotropic

substances and narcotic drugs under international control and in addition,
several substances and plants which fall under national control only. Also
included in the list are the chemical derivatives of the substances listed in the
national narcotics list plus any variation of the substance which are also

considered narcotic drugs. On December 19, 1997, regulations issued

concerning certain substances that may be used in the illicit manufacture of
narcotic drugs and psychotropic substances and precursors, implements the

European Community Directive n 92/109 issued December 14, 1992 (SIRUS
2001).
The Norwegian Civil Penal Code, section 162, first paragraph, supplies

the main provisions with regard to drug related felonies. It applies to anyone
who intentionally manufactures, acquires, imports, exports, stores, sends or

conveys narcotic drugs. The penalty for drug offenses pursuant to section 162
include fines and/or imprisonment not exceeding 2 years. Aggravated drug

felonies, addressed in paragraph 2, may be punished by imprisonment of not

more than 10 years. The criteria for a drug offense to be considered an
aggravated felony include the type of substance, significant quantities and the
sale to vulnerable groups, such as students, prison inmates and residents of
social institutions (SIRUS 2001).
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Drug cases in which a very considerable quantity is involved in the
offense is noted in paragraph 3 where the penalty is increased to a term of
imprisonment "of no less than 3 years and a maximum of 15". In an effort to
address large international drug trafficking, the second paragraph, item 2,

imposes a term of imprisonment not to exceed 21 years (maximum penalty

under Norwegian penal laws) for very aggravating circumstances (SIRUS

2001).
Actual practice in Norway has demonstrated that penalties for drug
offenses primarily depend upon the substance and quantity involved. In
addition, the nature of involvement with the substance, e.g., personal

consumption, is shown greater leniency than in cases which were motivated

by profit. Three recent Supreme Court rulings, (Rt. 1999, p.33 and p. 1504
and the Supreme Court Ruling of September 6, 2000) strongly express the

need to establish a distinct line between the purchase and storing of drugs
intended for private consumption and those intended for sale. The Ministry for
Social Affairs has appointed a committee, which was to submit a report by July

1, 2002, to summarize the existing knowledge in the field of substance abuse,
evaluate the need for further research and indicate policy dilemmas and
options in the upcoming years (SIRUS 2001).

D. Contrast in ,Dru-Related Law and Practice in Russia, Finland and
Norway:
Clearly, the national drug policies of Finland and Norway contrast with that
of the Russian Federation. Russia has chosen to implement draconian
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measures which rely almost exclusively on supply side measures and leave
little room for treatment and rehabilitation. To make matters worse, the current

state of the Russian criminal justice system has fostered a high level of
corruption among law enforcement officials. The implementation of a jury trial

system has been slowed by inadequate resources and political opposition.
Although their drug laws are relatively strict, Finland and Norway have chosen

to put into practice a demand side approach emphasizing prevention,

treatment, rehabilitation and maintenance. Examples of drug-related law
contrasted with the common practices of law enforcement in each country are
summarized in Table 11.
Table 11: Contrasting Drug-Related Law and Practice in Russia, Finland and Norway

Drug-Related Law

Practice in the

Practice in Finland

Practice in Norway

Russian
Federation

Use and Possession
of Small Quantities
of Drugs

Criminal Justice

System

Possession of up
to 1/1,000 of a
gram can draw as
much as three
years
imprisonment
Russia began jury
trials in 2002.
prosecutor has
broad powers and
may require pre-

Possession of small
quantities of drugs
brings a fine or
imprisonment not to
exceed 6 months

Prosecutor may

Prosecutor may

administer punishment
(fines) outside of court,
and frequently waive
punishment entirely

administer
punishment (fines)
outside of court, and
frequently waive
punishment entirely

trial detention in

Transfer to a
Treatment Facility in
Lieu of Prison Time
Substitution Therapy

"SIZO’s"
Not Available
Substitution

therapy is currently
Illegal

Possession of small
quantities of drugs
brings a fine or
imprisonment not to
exceed 6 months

Available on a
Voluntary Basis

Available on a
Voluntary Basis

Substitution therapy is
legal and available in
over 30 facilities using
buprenorphine,
methadone or

Substitution therapy
is legal and widely
available using
LAAM, methadone,
Subutex or high-

lavacetylmethadol

dosage

buprenorphine,

Possession of
Needles and

Syringes

Needles and
syringes may be
purchased legally
from pharmacies.
Police often harass
and arrest drug
users outside of
pharmacies
resulting in a
reluctance by drug
users to obtain
clean needles and

Syringe Exchange

syringes
A small number of

Programs

NEP/SEP operates

throughout the
country run by
various NGOs.
Police often harass
and arrest drug
users in the area of
NEP/SEPs
resulting in a
reluctance by drug
users to obtain
clean needles and
syringes

Possession of needles
and syringes is legal.
They may be

purchased at
pharmacies or available
for free at 13
counseling centers.

Possession of
needles and syringes
is legal. They may
be purchased at
pharmacies or
through vending
machines or for free
at supervised

"needle-rooms".

There are currently 13
counseling centers that
provide information on
risk factors for
infectious disease and
where IDUs may
exchange their
contaminated injection
equipment.

Clean needles and
syringes are
available at
supervised "needle-

rooms".

IV. E;)idemiology of HIVIAIDS and Related Diseases
A. Russian Federation
i. HIVIAIDS: The transition of the Soviet Union into independent republics has

led to an alarming increase in drug abuse accompanied by dramatic increases
in the incidence of infectious diseases such as HIV/AIDS, Hepatitis A, B and C

and Tuberculosis. President Vladimir V. Putin has attributed the increase in

drug abuse in part to the social and economic stresses associated with a
transition to democracy and a free market economy (INC 2002). In addition,

the increase in prostitution as an outgrowth of substance abuse and economic
dislocation has led to significant jumps in sexually transmitted infections

(STI’s) such as gonorrhea, syphilis and chlamydia.
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According to a report released in March, 2001 by the Joint United
Nations Programme on HIV/AIDS (UNAIDS) and the World Health

Organization (WHO), the prevalence of HIV infection is rapidly increasing.
Approximately 700,000 people in Eastern Europe tested positive for HIV in
2000, compared to 420,000 in 1999. Russia and Estonia reported many more

cases in 2000 than in any previous year and most (54%) new infections were
a result of injection drug abuse (IDU) (UNAIDS 2000). From 1999 to 2000, the
regions of Eastern Europe and Central Asia saw the largest jump (55%)in the
number of HIV/AIDS cases worldwide as compared to Sub-Saharan Africa

(17.7%), North Africa and the Middle East (25%), East Asia (25.5%), SouthEast Asia (16%), Latin America (12%), North America (5.1%) and the
Caribbean (18.2%) (NY Times 2001 ).

In much of the former Soviet Union (FSU), poverty, unemployment and
a crumbling public health system have led to a sharp rise in drug abuse and
prostitution causing epidemics of STD’s including HIV. Among the hardest hit
is Russia, where the number of people living with HIV has risen from 30,000 in

1999 to over 200,000 in 2002 (Table 12). The rate of HIV infection has
increased from 10.3 per million population in 1996, to 594 per million

population in 2000, a 58 fold increase (Table 12).
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TABLE 12: Total reported AIDS and HIV cases and by mechanism of transmission and incidence
rates per million population during year of diagnosis and adjusted for reporting delays (WHO
European Region 2002)
Reported

Reported

HomolBi

Injection

Heterosexual

Perinatal

AIDS
Cases

New HIV

Sexual

Drug Use
(N)

Contact

Transmission

(N)

(N)
AIDS
HIV

Year

1994
1995
1996
1997
1998
1999
2000
2001
2002*
Total

Infections

Rate/
Million

N

34
39
50
71
66
40
22

0.2
0.3
0.3
0.5
0.4
0.3
0.1

u/a
u/a

u/a
u/a

162
197
1,524
4,377
4,062
19,851
59,281
87,177
28,746
207,711

451

Rate/

Million
1.1
1.3
10.3

29.6
27.6
134.9
403.5
594.4
u/a

Contact
(N)

HIV

AIDS

AIDS

u/a
u/a

u/a
u/a

u/a
u/a

u/a
u/a

u/a
u/a

u/a
u/a

u/a
u/a

u/a
u/a

91
55
70
77
71
78
33
776

17
19
23
4
0

1,021
2,537
1,816
10,830
37,151
46,837
11,121
111,310

0
5
4
19
6

84
221
307
686
1,336
2,292
1,431
6,666

12
14
12
6
3

5
41
81
206
371
914
1,065
2,698

0
1
2
2
0

u/a
u/a

119

AIDS

HIV

HIV

u/a
u/a

29

u/a
u/a

72

u/a
u/a

7

January- June 2002
Technical note: Accurate and complete data on HIV in Russia are not available. The data presented here
are from a variety of sources and may not entirely agree. These data generally do not represent HIV
incidence, and depend heavily upon patterns of HIV testing and reporting that remain very incomplete in the
most severely affected countries. HIV infection is defined as an individual with HIV infection confirmed by a
laboratory according to country definitions and requirements. AIDS cases are reported according to a
uniform AIDS case definition originally published in 1982 and revised in 1985, 1987 and for adults and
adolescents (>age 13) IN 1993. The 1993 European AIDS surveillance cases definition differs from that
used in the United States in that it does not include CD4 lymphocyte criteria (European Centre for the

Epidemiological Monitoring of AIDS, 2002)

Data from the Ministry of Health and the Federal AIDS Center for the
Russian Federation are equally discouraging. According to the Russian

Government, the prevalence of HIV has increased from 0.7 in 1995 to 199.5
per 100,000 population in 2001 (Table 13).
Table 13: Data on new and cumulative HIV infections reported along with the incidence
rate per year and cumulative rate of infection for the years 1987 2002 as compiled by
the Ministry of Health and the Federal AIDS Center of the Russian Federation.

New Infections
Total Infections

1997

1990
103
438
0.3
0.1
1998

1991
84
522
0.4
0.1
1999

1992
88
610
0.4
0.1
2000

4,375
6,975

4,055
11,030

19,846
30,876

59,340
90,216

1987
23
23

1988
47
70

1989
265
335

1995

1996

196
1,074

1,526
2,000

Prevalence/100,000
ncidence/Year/100, 000

New Infections
Total Infections

1993
107
717
0.5
0.1
2001

1994
161
878
0.6
0.1
2002*

82,852 28,746
173,068 207,711
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Located near the border with Finland and Norway, the Murmansk
territory contains 1,080,000 inhabitants, of which 375,000 live in the city of

Murmansk itself. Current demographic trends show a movement towards the
city from rural areas. Up until 1996, the prevalence of reported HIV cases was

28. Incident cases for 1996 through 2000 were 6, 10, 20, 39 and 70
respectively, resulting in a cumulative total of 173 reported cases of HIV
infection at the start of 2001. The 472 incident cases of HIV reported in 2001

exceed the cumulative cases of HIV reported during the previous 14 years,
despite the fact that the number of H IV tests performed leveled off in 2000 at

approximately 20,000. Reported cases approximate 40% from the cities of

Murmansk and Kandalaksha with the remaining 20% spread among 17

surrounding smaller municipalities (Aavitsland 2001).
Alarming as these numbers may be, many experts feel they fall well
short of expressing the true severity of the problem. The national registration

system found in Russia likely captures a fraction of HIV infections understating
the real growth of the epidemic. While approximately 208,000 Russians are

registered as HIV positive, Dr. Vadim Pokrovsky, Director of the Russian
Federation AIDS Center estimates the actual number of cases closer to one
million. This number is expected to grow to five million by 2005 (Rodriguez

2002).

In addition, health officials are concerned about the spread of HIV from
IDU’s to their partners and possibly others. Officials fear a second wave of

H IV spread by sexual contact in 3 to 4 years following the current DU
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currently estimated that hepatitis C is the most common bloodborne infection
and has the greatest potential for long term morbidity. Most of those

chronically infected with hepatitis C lack any clinical signs of infection. These
individuals serve as sources of transmission to others and are themselves at

great risk of chronic liver disease or other HCV-related chronic illnesses over
the two decades following initial infection (MMWR 1998). While vaccines exist

for Hepatitis A and B, they are basically unavailable for mass distribution by
the cash strapped governments of the FSU, including the Russian Federation

(Garrett 1997). There is currently no effective vaccine against hepatitis C

(MMWR 1998).
Table 14: Incidence rates per 100,000 population for hepatitis A, B & C in the Russian
Federation, 1990 2000.
Disease

1990

1991

1992

1993

1994

1995

1996

1997

1998

1999

Mid-

year
Hepatitis

204.3

165.5

117.9

109.3

111.2

122.6

86.9

50.1

33.8

30.6

2000
15.9

21.9

17.9

18.2

22.2

27.0

35.2

35.8

36.5

35.8

43.3

21.7

u/a

u/a

u/a

u/a

3.2

6.8

8.4

9.1

11.6

19.3

10.9

A
Hepatitis

B
Hepatitis

C

(CDC 2001)

Additionally, the Hepatitis epidemic has followed a pattern not seen in
other areas. Since the appearance of HIV in 1981, Hepatitis epidemics have

tended to follow HIV, especially in IDU’s. However, in the Russian Federation,
Hepatitis B infection has preceded the appearance of HIV. Experts fear this

course may lead to taxed immune systems capable of only token resistance to

H IV. An immune system already compromised by fighting hepatitis infection
will likely be less able to control HIV and the progression to AIDS.

In addition,
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Hepatitis A, not known as a needle-borne virus, appears to be spreading

rapidly among drug user’s in the region (Garrett 1997).
iii. Tubercu!,osis" The deterioration of the tuberculosis

(TB) situation began

around 1992, when social and economic conditions worsened dramatically

(WHO 2003). Following a gradual decline in cases reported up until 1990,
estimated TB rates more than tripled in a trend reversal from 34 per 100,000

population in 1990 to 134 per 100,000 population, in 2001 (Table 15). The rate

of reported cases of TB has increased from 33.9 per 100,000 population in

1991 to 92 per 100,000 population in 2001 (Table 16 & Figure 4). The number
of reported cases of TB has increased from 50,407 in 1991 to 137,597 in 2000

(Table 16 & Figure 5) TB incidence rates increased 70% between 1990 and
1995 (CDC 2001), with incident cases doubling between 1990 and 2001

(WHO 2003). The rate of TB was 4.5% higher in 1999 than in 1998 (CDC

2001). Cases of Tuberculosis (TB)in Russia continue to rise climbing 12% in
2000 along with a 30% increase in mortality. The Russian Federation saw

more than 137,000 incident cases in 2000. In addition, the TB mortality rate
has nearly tripled since 1990, reaching 20 per 100,000 population in 2000,

resulting in the highest TB mortality rate in Europe. Tuberculosis ranks first in
mortality among infectious diseases within the Russian Federation (WHO

2003).
While the main cause of susceptibility to TB used to be alcohol abuse,

the current rise is being blamed on concomitant illnesses such as HIV/AIDS,
which itself has increased as a result of rising drug abuse (ITAR-TASS 2000).
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The deterioration of living conditions in Russia over the past 10 years is also
associated with the increase in TB rates. Susceptibility to infection by the TB
bacterium and active disease are exacerbated by factors which increase

exposure and/or decrease resistance. Food shortages, poverty, severe
overcrowding and poor ventilation as seen in Russian prisons along with large
numbers of undetected active TB and other immunosuppressive disorders
increase susceptibility to TB. These factors, coupled with a shrinking health

budget resulted in an erratic supply of anti-TB medications and laboratory
supplies, reduced quality control in TB dispensaries and labs and inadequate

treatment led quickly to multi-drug resistant strains of TB (CDC 2001).
According to the World Health Organization, a case of tuberculosis is

recorded if the presence of Mycobacterium tuberculosis is identified directly
using ZiehI-Neelson microscopy. If the Mycobacterium is identified through

culture, polymerase chain reaction or other diagnostic methods, the
cumulative case number some 15-fold (CDC 2001). Although the Russian
surveillance system identifies the majority of cases, detection rates as defined

by WHO remain low (31%) (Table 15). This is because many cases are not
confirmed through bacteriologic testing and smear microscopy is not routinely

performed. The heavy reliance on x-rays for diagnosis likely means that some
reported cases do not have TB (WHO 2003).
The situation is even more devastating in Russia’s prison system where

TB incidence and mortality among prisoners are ten times higher than in the
civilian population. In 2000, the case notification rate was 3,118 per 100,000

61

including the convicted and persons under criminal investigation. These

factors may further burden TB control among the civilian population as TB
infected prisoners are released into the community. The compulsory

imprisonment of drug offenders, many of whom carry HIV, has provided an
excellent mechanism for transmission of TB including several antibiotic
resistant strains. TB case rates are some 30 times higher in prisons than in

the general population (WHO 2003). Although several government programs

throughout the FSU, including the implementation of Directly Observed

Therapy Supervised (DOTS), have demonstrated some success in controlling
the spread of TB among prisoners, health officials face an uphill battle against

an infection which in some prisons affects 50% of the population (Garrett,

2000).
DOTS stands for "Directly Observed Treatment, Short-Course, and is
an internationally recognized health care management system" (SA Health

2003). The DOTS system utilizes a patient-based approach which provides
support through direct observation of patients while they take their TB drugs.
This helps to provide effective drug treatment while monitoring the patient’s

progress toward a cure. The DOTS program also assists in identifying
individuals in the infectious stage of TB through the monitoring of sputum

samples under microscopy (SA Health 2003).

A special network of facilities, which have not been integrated into the
general health care system, provides TB control in the Russian Federation.
The care and treatment of individuals with TB is provided by a network of TB
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specialized dispensaries and hospitals. TB patients are also treated in prisons

under the auspices of the Ministry of Justice. The Ministry of Health is

currently attempting to reorganize these services to link TB control with the
primary health care network (WHO 2003).

By the end of 2001, Directly Observed Therapy (DOTS) had been
implemented in nineteen pilot projects among both civilian and prison
populations and DOTS-Plus was implemented in one prison. This represented

a population coverage of 16% (Table 15). Beginning in January 2002, 20
additional pilot projects were scheduled to begin. Data reported from ten
Russian territories covering the first half of 2000 indicated a 68% treatment

success rate (Table 15). This less than optimal success rate was attributed to
late diagnosis (6%), treatment failures often linked to drug resistance (13%)
and treatment interruption (9%), especially among the homeless, drug abusers
and alcoholics (WHO 2003).
Table 15: Overview of tuberculosis control in the Russian Federation at the end of
2001.

Latest Information:
Population"

2001

144,664,291

Trends"

1997 1998 1999 2000 2001

DOTS population

Coverage (%)

5
92

12
95

16
92

28

32

31

1

2

3

5

68

65

68

68

65

68

1

1

1

Global rank

2
5
81
Notification rate
76
(all cases/100,000 population)
60
Detection
57

(by estimated number of cases)

(new ss+ cases, %)

Estimated Incidence

134

(all cases/100,000 population)

DOTS detection

Regional rank

1

(new ss+, %)
Est. adult (15-49y) TB cases
That are HIV positive (%)
Est. multi-drug resistance

(new cases, %1

DOTS status (year adopted)
WHO Control Category:

1996

Treatment success 67
Countrywide (new ss+,%)
Treatment success
67
under DOTS (%)
Est. new ss+ success
under DOTS (%)
1

64

iv. Sexually Transmitted Infections" While the struggling economies of the

FSU have fostered a dramatic rise in substance abuse, the very same
economic difficulties have led to an increase in prostitution to support daily

living and possibly drug habits. While providing an excellent vehicle for the

spread of HIV it has also led to epidemics of other sexually transmitted
infections (STI) particularly syphilis. The number of incident cases of syphilis

registered annually has risen from 8,000 in 1990 to 388,000 in 1996 and

405,000 in 1997 (Table 17). Virtually all parts of the FSU report rapid
increases in the incidence of syphilis since 1991. Although data is scarce and

of somewhat dubious reliability, the prevalence of many STI’s including
chlamydia, gonorrhea, herpes and trichomoniasis all appear to be rising
dramatically throughout the region (DET 1999). For example, despite the

apparent decline in the incidence of syphilis beginning in 1998, experts do not
believe this decline is real. The official numbers released by the government

are based upon a system of state registration left over from the days of the
Soviet Union. Recently, commercial medical services have expanded, offering

anonymous treatment without registration. This eliminates an increasing
number of cases from the records (Johnson, 2002).
While the actual determinants are variable, a recent rise in prostitution

at least somewhat attributable to the rise in drug abuse appears to be
somewhat responsible (DET 1999). The potential overlap between the still

uncontrolled epidemic of syphilis and HIV remains to be seen. The spread of

STI’s is closely linked to prostitution and drug addiction, as prostitution helps
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to cover the cost of drugs (Johnson 2002). However, rapid changes in sexual
norms and behaviors and the growing commercial sex industry coupled with
the huge economic and socio-political crisis have created a fertile environment

for the spread of HIV (Atlani et al 2000).
Table 17: Number of new cases and Incidence rates per 100,000 population for
syphilis, gonorrhea and chlamydia in the Russian Federation, 1991 2001.
Syphilis

Gonorrhea
Rate
Number

Chlamydia

Year

Number

1991

10,704

7.20

190.693

128.26

u/a

u/a

1992

19,890

13.37

251,538

169.05

29,754

20.00

1993

50,074

33.68

340,957

229.31

54,813

36.86

1994

126,551

85.25

301,695

203.23

90,839

61.19

1995

261,908

176.80

256,611

173.22

133,446

90.08

1996

388,247

262.73

203,920

137.99

155,802

105.43

1997

405,746

275.38

167,046

113.38

169,834

115.27

1998

342,657

233.38

150,386

102.43

166,111

113.14

1999

271,699

185.83

174,444

119.31

181,609

124.21

2000

239,391

164.54

175,954

120.94

182,672

125.56

2001

207,157

143.20

156,721

108.33

175,255

121.15

Rate

Number

Rate

(WHO 2002)

B. Finland
i. HIM/AIDS: As of June 30, 2002, Finland has reported a cumulative total of

1,430 cases of HIV (Table 18). Of the 1,430 cases, 34% were transmitted
through heterosexual contact, 31% through homo or bisexual contact, 18%

through injection drug use and 1% through perinatal transmission (Figure 6).
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As of June 30, 2002, a cumulative total of 339 cases of AIDS have
been reported (Table 18). Of the 339 cases, 26% were attributable to

heterosexual contact, 63% to homo/bisexual contact, 4% to injection drug use,

3% to blood products and 1% to perinatal transmission (Figure 7) (WHO

2001).

By the end of 1997, 864 cases of HIV had been reported, 28 of which

(3%) had been transmitted through injection drug use (only two were
transmitted in Finland, 26 transmitted elsewhere). In 1998, 19 of the 80 (24%)
incident cases of HIV cases were transmitted through injection drug use,

mostly in the area of Helsinki. In 1999, 86 of 142 (61%), in 2000, 57 of 146

(39%) and in 2001,48 of 128 (38%) new cases of HIV were transmitted
through injection drug use. During the first six months of 2002, 15 of the 69

(22%) new cases of HIV were transmitted through injection drug use,
suggesting a decline and possible leveling off of HIV transmission through IDU
since the high of 1999 (Table 18/Figure 6). The cumulative number of

reported HIV infections transmitted through injection drug use is 252 out of the

1,430 total (18%) (Figure 7). The cumulative number of reported AIDS cases
transmitted through injection drug use is 13 out of 339 total cases (4%) (Figure

8). A seroepidemiologic study conducted in 1998 determined that 3% of
injection drug users in Finland were infected with HIV. In 2000, voluntary HIV

tests carried out in prisons and at needle exchange centers indicated that
2.5% of those tested were positive for HIV (STAKES 2001).
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hepatitis C in Finland are attributable to injection drug use. The strong
correlation between injection drug use and hepatitis C has brought some in

Finland to call for the use of hepatitis C prevalence as an indicator of drug use

trends. In 2000, there were 1,739 reported incident cases of hepatitis C, over
half of which involved persons under the age of 30, most among 20-24 year
olds. The incidence of hepatitis C is believed to have remained fairly constant,
between 1,500-1,700 cases in 2001 (STAKES 2001).
Follow up on injection drug users at the Vinkki counseling center in
1997 revealed that 25% of clients exchanged contaminated needles, 50%
tested positive for hepatitis C, 33% tested positive for hepatitis B, but no one
tested positive for HIV. It was not until 1998 when the first client tested

positive for HIV. Follow up in 1998-1999 revealed 25% of clients testing
positive for hepatitis B, likely owing to an increase in hepatitis B vaccinations

(STAKES 2001).
In 2002, 385 microbiologically confirmed cases of hepatitis A were
reported in Finland resulting in an incidence rate of 7.4 per 100,000
population. This was significantly higher than the period 1999- 2001, when

between 48 and 51 cases were reported for an incidence of 1.0 per 100,000
population for each of the three years. Of the reported cases of hepatitis A in

2002, 260 (68%) took place in the Helsinki and Uusimaa Health District (HUS),
which is the most highly populated district in Finland. By year end, residents

of Helsinki accounted for 178 (46%) of cases; an incidence of 31.8 per

100,000 population (Eurosurveillance 2003).
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Interviews during early 2002 indicated that nearly all cases were

injection drug users or could be linked to IDU’s. Later in the year, a growing
number of cases (33%) were identified in individuals with no history of drug

abuse. Several smaller outbreaks were also detected in other health districts

throughout Finland, most of which were tied to injection drug use

(Eurosurveillance 2003).
Although both hepatitis A and B vaccinations are recommended for

IDU’s in Finland, hepatitis A vaccination is not included in the national
vaccination program. Individuals must pay out of pocket for hepatitis A
vaccination (Eurosurveillance

2003).

The extent of the hepatitis A outbreak was likely buffeted by the
administration of hepatitis A vaccine to close contacts of cases during the first

three months of 2002. This was followed in April by a campaign to vaccinate

IDU’s against hepatitis A in Helsinki at needle exchange sites, which were
utilized to reach the IDU population (Eurosurveillance 2003).
iii. Tuberculosis: The number of TB cases reported has declined from a high

of 2,247 cases in 1980 to a low of 460 cases in 2001 (Table 19/Figure 9). The

rate of reported cases of TB has declined from a high of 47 per 100,000
population in 1980 to a low of 9 per 100,000 in 2001 (Table 19/Figure10)

(WHO 2002). This decline is credited primarily to the efforts of the National
Public Health system (Table 20).
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TABLE 21" Total reported AIDS and HIV cases and by mechanism of transmission and incidence
rates per million population in Norway during year of diagnosis and adjusted for reporting delays
(WHO European Region 2002)

Year

Reported AIDS

Reported

Homo/B!

Injection

Heterosexual

Perinatal

Cases

New HIV

sexual

Drug Use
(N)

Contact

Transmission

(N)

(N)
HIV AIDS

Infections
Rate/
Million

Rate/

Contact
(N)

HIV

AIDS

HIV

AIDS

HIV

AIDS

Million

u/a
u/a
u/a
1994
74
u/a
u/a
u/a
17.1
95
22.0
ula
u/a
u/a
u/a
u/a
1995
67
u/a
u/a
15.4
106
24.3
ula
u/a
u/a
u/a
u/a
u/a
u/a
1996
u/a
56
12.8
107
24.4
1997
34
7.7
117
2
26.6
64
14
34
11
11
8
1998
39
101
17
1
22.8
13
62
5
29
8
28
1999
6.3
3
136
88
10
30.6
33
6
12
12
2000
38
8.5
169
37.8
3
7
7
21
32
9
122
27
2001
6.0
163
3
112
14
36.3
37
8
8
5
u/a
u/a
2002*
8
11
96
72
13
6
2
28
750
1027
192
Total
2,417
804
462
130
375
2002 figures are from January 1 June 30, 2002
Technical note: Accurate and complete data on HIV in Norway are not available. The data presented here
are from a variety of sources and may not entirely agree. These data generally do not represent HIV
incidence, and depend heavily upon patterns of HIV testing and reporting that remain very incomplete in the
most severely affected countries. HIV infection is defined as an individual with HIV infection confirmed by a
laboratory according to country definitions and requirements. AIDS cases are reported according to a
uniform AIDS case definition originally published in 1982 and revised in 1985, 1987 and for adults and
adolescents (>age 13) IN 1993. The 1993 European AIDS surveillance cases definition differs from that
used in the United States in that it does not include CD4 lymphocyte criteria (European Centre for the
Epidemiological Monitoring of AIDS, 2002)

As of December 31,2000, figures from the Norwegian Institute for
Public Health show 448 individuals diagnosed with HIV having a risk factor for

injection drug use (Table 22). Among those who had developed AIDS, 119 or

17% of the total number of AIDS cases were injection drug users. However,
the number of incident cases of both HIV and AIDS among injection drug

users is considered low. A significant number of injection drug users who
developed AIDS are now deceased. In addition, a large proportion of HIV
positive injection drug users have died of other causes. According to recent
studies, over 90% of injection drug users report being tested, thus the number

of undetected infections is considered to be low (WHO 2002).

u/a
u/a
u/a

0
2
0
0
0
0
6
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Table 22: Number and percentage of individuals diagnosed as HIV positive and
diagnosed with AIDS in Norway who are injection drug users for the years 1984- 2000.

Year

Total

HIV

HIV +

Percentage
of HIV +
Injection
Drug
Injection
user
Drug User
315
35%

Total

AIDS

Percentage
of AIDS
Injection
Drug
Injection
User
drug User
AIDS

1984-89

894

1990

90

22

24

59

13

22

1991

142

16

11

59

16

27

1992

105

12

11

50

1993

113

13

12

64

13

20

1994

94

12

13

74

19

26

1995

105

11

10

67

1996

116

1997

112

1998

98

1999

147

2000

177

Totals

2,194

56

11

10

12

448

20%

6%

144

16

12
12

21

34

24

36

14

21

14

38

16

703

119

17%

(National Institute for Public Health 2001)
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In Norway, HIV testing is systematic for blood donors, pregnant women
and patients with sexually transmitted infections (STI). Diagnosed HIV cases

are reported in a national HIV database which utilizes an identifying code

(WHO ntroduction of hepatitis B immunization programs in 1984 aimed at high
risk groups, the incidence of hepatitis B has gradually declined. Hepatitis B
vaccines have been offered to all drug users at no charge since 1985

(EpiNorth 2000). 2002).
ii. He)atitis" The incidence rate of hepatitis A averaged approximately 100

cases reported annually through the 1970’s, 1980’s and early 1990’s with
almost half of the cases acquired abroad. Hepatitis A vaccines have been

offered to drug users at no charge since 1997. Prior to this, vaccines were

offered at no charge only in cases of local outbreaks of hepatitis A. With the
introduction of immunization programs in 1984 aimed at high risk groups, the
incidence of hepatitis B has gradually declined. Hepatitis B vaccines have

been offered to all drug users at no charge since 1985 (EpiNorth 2000).

However, during the five-year period of 1995- 1999, 1,343 cases of
hepatitis A (Table 23) and 998 cases of hepatitis B (Table 24) were identified
in injecting drug users by the Norwegian Surveillance System for

Communicable Disease (MSIS). Many of these cases had serological
indicators of possible double infection with both hepatitis A and B. In addition,

the prevalence of hepatitis C is thought to be high among IDU’s. These

numbers are believed to be on the low side as many drug users remain
asymptomatic and do not seek medical care (EpiNorth 2000).
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The hepatitis A outbreak was characterized by local outbreaks in
different parts of the country, in particular, major cities with large IDU

populations. The virus was believed to be transmitted among IDU’s primarily

through contaminated syringes and needles and sustained through the fecaloral route. The outbreak peaked in 1999 with 998 reported cases,
representing an incidence rate of 22.4 cases per 100,000 population, the

highest incidence of hepatitis A in Norway since 1959 (EpiNorth 2000).

In contrast, the outbreak of hepatitis B was reported from all areas of
the country. The reason for this is unknown but possibly due to the presence

of chronic hepatitis B carriers. Most cases of hepatitis B are thought to be
associated with intramuscular and subcutaneous injections by so-called "skin

poppers" (Eurosurveillance 2001). The incidence of hepatitis B peaked in
1999 with 472 reported cases representing an incidence rate of 10.6 per

100,000 population, the highest incidence of hepatitis B in Norway since 1975

(Epinorth 2000).
The outbreak of hepatitis A appeared to be in decline at the end of

2000 but large numbers of hepatitis B cases are still being reported among

IDU’s. During the period 1995 2000, a total of 1,353 cases of hepatitis A
and 1,136 cases of hepatitis B were reported. In addition, a number of cases
had serological indicators of hepatitis C in addition to both hepatitis A and B

(Eurosurveillance 2001).
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Table 23: Reported cases of hepatitis A in Norway by transmission category, 1995

1999.
1995

1996

1997

1998

1999

Injecting Drug

110

273

150

278

532

Use
Contacts of
Drug Users

10

82

25

19

60

Travel Abroad

68

73

86

56

84

Others/Unknown

62

93

73

154

322

Total

250

521

334

507

998

Transmission

Category

Table 24: Reported cases of hepatitis B in Norway by transmission category, 1995
1999.
Transmission

1995

1996

1997

1998

1999

Category
Injection

39

55

135

385

374

Drug Use
Sex

37

27

29

69

74

Unknown

17

11

14

10

18

Total

99

96

185

469

472

Others

The number of reported cases of hepatitis C does not reflect a true

prevalence rate as reporting is only required in the case of acute infection.

Acute cases of hepatitis C were reported in the years 1997, 1998, 1999 and
2000 to be 13, 17, 15 and 11 respectively. The prevalence rate of hepatitis C

was 0.1 in 1999 (WHO 1999). The majority of newly infected individuals does

not experience symptoms and therefore do not seek medical attention. In
addition, once hepatitis C is diagnosed it is rarely possible to identify the time

of infection. These two factors make it nearly impossible to define the
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incidence of hepatitis C in Norway with any degree of accuracy. Thus, these

figures represent an unreliable incidence rate for disease. However, it is
believed that a significant number of injection drug users have been infected
with hepatitis C.

Numerous prevalence studies indicate that 50-80% of drug

addicts in Norway tested positive for anti-HCV (SIRUS 2001).
iii. Tuberculosis" The number of TB cases reported in Norway has gradually

declined over the period of 1980 to 2000 (Table 25/Figure 15). During that

period, the highest level of reported TB cases was 499 in 1980, and the lowest

was 205 recorded in 1997. After a small spike in 1998 of 244 cases, the level
again declined to 221 in 2000, before increasing to 276 in 2001. The reported

TB case rate has also steadily declined from a high of 12 per 100,000
population in 1980 to a low of 6 per 100,000 population which has been
maintained since 1995 (Table 25/Figure 16) (WHO 2002).
Table 25: Reported incidence and incidence rates per 100,000 population of TB in
Norway for the years 1991 2001

TB Cases
Reported
Reported

1991
290

1992
288

1993
256

1994
242

1995
236

1996
217

1997
205

1998
244

1999
213

2000
221

2001
276

6.8

6.7

6.0

5.6

5.4

5.0

4.7

5.6

4.8

4.9

6.0

TB Case
Rate per
100,000
population

Control of TB in Norway has been credited primarily to the routine
implementation of Directly Observed Therapy, Supervised (DOTS) in over

90% of the total Norwegian population (Table 26). The treatment success rate
with DOTS is over 77% and the re-treatment success rate is 100% (Table 24).
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Less than ten cases of gonorrhea and syphilis are linked to Russia
implying the epidemiological situation is stable (Table 27). Reasons for this
include: Russians and Norwegians may not engage in sexual relations with

each other, sexual relations are protected through condom use or that
Russians who engage in sex with Norwegians are not infected (EpiNorth

2000).
Table 27: Distribution of cases of gonorrhea and syphilis reported in Norway with links
1999.

to Russia, 1993

Norwegians Infected
In Russia

Norwegians Infected
By Russians in

Russians Diagnosed

In Norway

Norway
Gonorrhea
Syphilis
Total

15
6
21

7
2
9

4
11

(EpiNorth 2000)
Epidemics of syphilis and gonorrhea may be used as markers of
behavior which increase the spread of HIV. In addition, the presence of

syphilis and gonorrhea increase the infectiousness of HIV. Thus, it is critical
that close surveillance of these diseases is maintained. The successful
eradication campaigns for syphilis and gonorrhea in Norway should prove
instructive for Russia. It would seem beneficial to the region for public health
officials from both countries to combine efforts to control the spread of sexually
transmitted infections (EpiNorth 2000).

D. Comparison of the Ec}idemiological Situations in Finland, Norway and
the Russian Federation
i. HIVIAIDS" According to the Russian

Government, the prevalence of HIV in

Russia at the end of 2001 was 199.5 per 100,000 population. The incidence

of HIV was almost 603 cases per 100,000 population in the year 2001. The
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total number of reported HIV infected individuals in the Russian Federation

numbered 207,711 as of June 30, 2002 (Figure 17). Of the 207,711
cumulative reported HIV infections, 54% were transmitted through injection

drug use, which represents the primary mechanism of transmission. (Figure

18) (Russian Gov’t 2002). As dismal as these numbers are, many among the
Russian public health community fear the actual numbers may be ten times

higher.

As of June 30, 2002, the total reported cases of HIV and AIDS in
Finland number 1,430 and 339 respectively. The incidence of HIV was 24.7

per 100,000 population in 2001, and the incidence of AIDS was 3.3 per
100,000 population in 2001 (Figure 17). Of the 1,430 cumulative cases of

HIV, 18% were transmitted through injection drug use. The primary
mechanisms of transmission of HIV in Finland are heterosexual contact (34%)

and homosexual/bisexual contact (31%) (Figure 18) (Euro 2003).

As of June 30, 2002, there were 2,417 reported cases of HIV and 750
reported cases of AIDS in Norway. The incidence of HIV in 2001 was 36.3 per
100,000 population. The incidence of AIDS over the same period was 3.3 per
100,000 population Figure 17. Of the 2,417 cumulative reported cases of HIV,

19% were transmitted through injection drug use. The primary mechanisms of
transmission of HIV in Norway are heterosexual contact (42%) and
homosexual/bisexual contact

(33%) (Figure 18) (Euro 2003).
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ii. He)atitis" Hepatitis B

& C rates in the Russian federation climbed steadily

throughout the 1990s. Hepatitis B rates doubled between 1990 and 2000 and
hepatitis C rates more than tripled (x3.4) between 1994 and 2000. The
epidemic of hepatitis B was unusual in that it preceded the outbreak of HIV,

leaving compromised immune systems in its wake capable of only token
resistance against HIV. Hepatitis C has become the most common blood-

borne infection in Russia and presents the greatest potential for long-term

morbidity from chronic liver disease. Most individuals infected with hepatitis C
lack clinical signs of infection and serve as a source of transmission to others.
Vaccines against hepatitis A & B are not widely available due to cost factors,

especially in areas with large concentrations of high-risk populations where it
is needed most (MMWR

1998).

Prevalence rates of hepatitis C in Finland remain low (0.02 in 1999).

However, 60% of injection drug users tested positive for hepatitis C infection in
1999. It is estimated that 90% of hepatitis C infections in Finland are
attributable to injection drug use. Localized outbreaks of hepatitis A among

DUs in 2002 appears to be under control due to an aggressive, national free
vaccination program (STAKES 2001).

Norway has averaged 100 cases each of hepatitis A and hepatitis B
throughout the 1970s, 1980s and 1990s. Approximately one half of these

cases were acquired abroad. However, the period between 1995 and 1999
was characterized by localized outbreaks among injection drug users. The
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epidemic of hepatitis A peaked in 1999 with 22.4 cases per 100,000

population, but has been in decline ever since due to widespread vaccination.

The hepatitis B outbreak also peaked in 1999 at 10.6 cases per 100,000
population, but remains high among IDUs. Infection rates for hepatitis C are
considered unreliable primarily due to the fact that many infected with hepatitis

C remain asymptomatic and do not seek treatment. However, public health
estimates that some 50

80% of the IDU population is infected with hepatitis

C (EpiNorth 2000)
iii. Tuberculosis" The rise in the incidence of tuberculosis correlated with the
decline of the socioeconomic situation in Russia beginning in 1992. The rate

of reported cases of TB more than doubled (x2.7) from 33.9 per 100,000
population in 1991 to 92 per 100,000 population in 2001 (Table 28). The

number of reported cases of TB also more than doubled (x2.7) from 50,407 in

1991 to 137,597 in 2000 (Table 28/Figure 19). The incidence of TB increased

70% between 1990 and 1995. The number of reported cases of TB continued

to climb, rising 12% in 2000 coupled with a 30% rise in mortality. Tuberculosis
is currently first in mortality among infectious diseases in Russia and the

mortality rate of 20 per 100,000 cases in 2000 was the highest in Europe.

DOTS population coverage was 16% in 2001 with additional pilot programs in
the planning stage (WHO 2003).

The number of reported cases of TB in Finland declined from a high of

2,247 in 1980 to 460 in 2001 (Table 28/Figure 19). The TB case rate declined
from 47 per 100,000 population in 1980 to 9 per 100,000 population in 2001
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(Table 28). The decline is credited mostly to aggressive diagnosis and
treatment by the Finnish public health system (WHO 2002).
The number of reported cases of TB in Norway declined between 1980
and 2000 reaching a low of 205 cases per 100,000 population in 1997 (Table

28/Figure 19). Norway has implemented the DOTS program in over 90% of
the country. The treatment success rate for DOTS is 77% with a 100% re-

treatment success rate (WHO 2002).
Table 28: Comparison of reported cases of TB, case rate per 100,000 population, new
smear positive (ss+) cases, smear positive rate per 100,000 population, new confirmed
cases of TB, new confirmed TB case rate per 100,000 population, estimated cases of TB
and estimated case rate per 100,000 population, estimated smear positive (ss+) and
estimated smear positive (ss+) case rate, and TB detection rate and new smear positive
cases of TB detected in Finland, Norway and the Russian Federation, 2001.

2001

Population
Total reported
cases of TB

Case rate per
100,000
population
New ss+ cases
reported
New ss+ cases
reported rate
per 100,000
population
New confirmed
cases of TB
New confirmed
cases of TB per

Finland

Norway

Russian
Federation

5,178,000
460

4,488,000
276

144,664,000
132,477
92

150

59

26,605

18

280

147

4,446

568

265

193,363

100,000

population
Estimated

cases of TB
Estimated

cases of TB per
100,000
population
Estimated ss+
cases of TB
Estimated ss+
cases of TB per

134

11

251

119

86,917

60

The prevalence of sexually transmitted infections is relatively low in
Finland. The primary mechanism of transmission has been through

heterosexual contact abroad. There has been an increase in cases of syphilis
since 1993, with cases nearly doubling (xl.9) between 1994 and 1995. More

than half of the 1995 cases were acquired in Russia along the southern
Finnish border (Eurosurveillance 1996).

The incidence of syphilis in Norway has decreased from 328 cases in

1975 to an average of 10 annually since 1993 due to rigorous diagnosis and

treatment standards. The majority of cases are transmitted abroad, with
growing concerns along the border with Russia (EpiNorth 2000).

V. Public Health Interventions to Reduce Disease and Other Injuries
Associated with Drug Use
A. Russia
This section will cover public health strategies in both law and practice
which may potentially decrease the spread of HIV and related infectious
diseases among drug users. These strategies include primary harm reduction

interventions such as education and increasing public awareness, treatment

and its availability and maintenance therapy to prevent relapse.
The Government of Russia has limited resources devoted to public

health. Health care funding, as a percentage of Gross Domestic product

(GDP) has changed little over recent years and remains woefully inadequate
at 2.6% (1990), 4.5% (1995) and 4.6% (2000) respectively (World Bank 2003).
The result is an almost complete lack of primary prevention interventions and
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the absence of acceptable services targeted at vulnerable population groups

(DET 1999).
While Russian authorities have expressed an interest in developing a

comprehensive counter-drug strategy which would incorporate education,
healthcare and law enforcement, little in the way of harm reduction has been

put into practice. Supply side law enforcement still commands the majority of
the little monies available. In the 2003 budget, the government identified five

target areas for increased funding, none of which include healthcare, drug
abuse prevention or treatment (World Bank 2003).

The prevalence of HIV and related infections is much higher in the
prison system than in the general public. The stiffening of Russian drug laws
has led to overcrowding in prisons which has facilitated the spread of
infectious disease. While the Ministry of Justice, which runs the countries

prisons, has pushed to reduce overcrowding, change is often haphazard and
slow. Access to condoms is restricted as sex is not allowed. Bleach, which

can be used to sterilize injection and tattooing equipment, is also restricted for
fear it could be used to attempt suicide or to injure prison guards or fellow
inmates (Schoofs 2002).

Under Russian law, mandatory testing is required for all new prisoners

upon arrival. However, in practice, only those individuals who "appear sick"
are actually tested. Often, prisons run out of money and cannot afford to but
testing equipment. In addition, the HIV test works by detecting the presence

of antibodies to HIV, not the virus itself. Since it may take an immune system
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up to six months to produce antibodies to HIV, false negatives may occur.

Any one suspected of carrying HIV or other infections such as TB and
hepatitis are supposed to be segregated by different cellblocks. However, due

to inconsistencies in testing, HIV infected prisoners are often placed among

HIV negative inmates. Under a false sense of security, these prisoners often
share injecting equipment thinking it is safe and ultimately spread the infection

(Schoofs 2002).
The Russian medical establishment is largely resistant to reforming the

penal system and drug treatment. Many influential Russian physicians were
educated under the old authoritarian Soviet public health system. They

strongly oppose the employment of harm reduction strategies in the treatment
of injection drug use and control of HIV. Many physicians, including Alexei

Mazus, Director of the Moscow AIDS Center, resist needle exchange
programs for fear that they "lure youths into drug addiction" (Schoofs 2002).
Additional opposition comes from the police, clergy and politicians. The

general public’s perception is often based on negative media portrayals of
harm reduction programs (WHO 2001). Since 1997, small-scale needle

exchange programs have been operating in several cities. However, law

enforcement officials hinder their operations by frequently harassing or even
arresting those who attempt to utilize these programs. (WHO 2001). There is

strong opposition from city administrators and neighborhood groups
(businesses, residents, etc.) to needle exchange programs (DET 1999).
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Most harm reduction programs depend on funding through NGO’s and
the international community. The Russian Federation has received

approximately 37 grants for needle exchange and methadone projects from
1996 through 2000 (WHO 2001).
While vaccines are available to prevent hepatitis A & B, they are costly

and generally unavailable in Russia. While hepatitis A is controlled mostly

through careful monitoring of food and water, this is not occurring in Russia

(OSI 1999).
i.

Dru Treatment ProramslAvailability: The 1998 Russian Law on

Narcotics and Psychotropic Substances provides for compulsory treatment of

drug abusers who come to the attention of authorities. The 1998 Law restricts
drug abuse treatment to government facilities. Russian counter-narcotics
efforts rely heavily on law enforcement, but authorities have recently displayed

an increased interest in initiating cooperation and accepting assistance in the
areas of drug abuse prevention and treatment (INC 2001). However, since

funding is limited and methadone is illegal, drug treatment usually consists of
detoxification and a daily routine of vitamins and painkillers (Rodriguez 2002).

Substitution therapies are generally unavailable due to the illegality of

methadone and opposition to this form of therapy from physicians, politicians,

clergy, police and the general public (DET 1999), (INC 2001). Russian
prisoners suffering from heroin withdrawal often resort to used needles and

syringes and whatever drug(s) may be available (including homemade drugs)

to relieve the stress of withdrawal (Schoofs 2002).
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ii. Sociopolitical Environment in the Russian Federation" Social attitudes

toward drug use and IDUs are mostly negative. The general perception of HIVinfected injection drug users is that they are "guilty" or responsible for their

own infection. Therefore, as carriers of a dangerous disease they must be
avoided. The media helps to fuel this negative public perception by referring

to injection drug users as "hopeless junkies". The general attitude from
politicians, clergy and the medical profession to the general public is that drug

users should face criminal punishment. The police often harass and arrest

drug users sending them underground (OSI 1999).
Russia has taken some measures to effectively prevent HIV

transmission in the most affected regions. Risky drug preparation practices

have been reduced following the dissemination of targeted information and
education among drug users in the most highly affected areas such as

Moscow, St. Petersburg and Kalingrad. However, other regional and national
policies have further increased the risks associated with injection drug use by
driving many drug users underground, effectively rendering them unreachable.
Arkadiusz Majszyk, the Russian Federation’s representative to the United
Nations program on HIV/AIDS estimates that needle-exchange programs

reach approximately 5% of the injecting population. Majszyk believes 60%

coverage is necessary to slow the spread of HIV among IDU’s (Rodriguez

2002).
The traditional approach to prevention in prisons remains testing, with
the goal of segregating HIV infected prisoners from those which are HIV
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negative. Small gay groups have emerged but generally only target other gay
inmates with prevention messages (OSI 1999).
Official approaches to sex work and HIV prevention among sex workers

have so far been characterized by either negligence or repression. Lacking

legislation against sex work, prostitutes are frequently detained with no legal
basis or because they do not have the required residence documents.

Reportedly, the police in Moscow occasionally become involved in pimping

(OSI 1999).
iii. Proqrammatic Details" HIV testing is widely available. According to

Russian law, anyone who wants an HIV test can obtain one anonymously. As

of December 31, 2000, the rate of testing per 1,000 population was 27.3 (Euro

2002) The number of tests performed decreased 43% between 1994 and
1996, due in large part to the change in testing policies and decreased
funding. However, the number of tests decreased 33% in blood donors and

54% in prisoners for whom testing policies remain the same for lack of funding

(DET 1999). The total number of HIV tests performed, excluding unlinked
anonymous testing and the testing of blood donations by year (1997 2001)
and rate of testing per 1,000 population were"

1997:16,480,739
1998:16,337,404
1999:18,205,730
2000:20,387,206
2001: 19,810,751

Tests per 1,000 population/habitants in 2001" 135.1
(European Centre for the Epidemiological Monitoring of AIDS 2002)
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B. Finland
The HIV epidemic in Finland began in 1998 among injection drug users.

The relationship between injection drug use and HIV and related infectious
disease has served to underscore the importance of reducing the health

hazards associated with drug abuse. Despite public awareness, few Finnish

treatment facilities engage in needle exchange programs. Although most
pharmacies formerly sold syringes to addicts, nearly one quarter have stopped

doing so, citing reasons of security. Additionally, most pharmacies report that

they do not sell syringes to minors. In response, the Ministry of Social Affairs
and health, the National Agency for Medicines, the National Public health
Institute, the Association of Finnish Pharmacies and the University Pharmacy

have all sent recommendations encouraging pharmacies to sell syringes to

drug users (STAKES 2001).

Currently, Health (infection risk) counseling services for injection drug
users are operating in thirteen municipalities in Finland. This number includes
one syringe exchange program. The goal of the counseling service is to

encourage drug users to reduce behaviors associated with the risk of
infectious disease. Clients receive information regarding the risks of using
contaminated needles, syringes and other drug paraphernalia and are able to

exchange their contaminated needles. The longest running health counseling

center in Finland is Vinkki which has operated in Helsinki since 1997. The
Vinkki Center reports that the average client participates in their needle

exchange program six times per year. Condoms are made available and
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visitors receive information regarding sexually transmitted diseases. The

primary goal of counseling is to motivate drug addicts to seek help and

treatment so they may eventually abandon their drug habit (STAKES 2001).
The national Public Health Institute launched a project in 1999 in an
effort to lower the technical requirements to perform H IV testing. The project
included both theoretical and hands-on training in the use of HIV tests and

aspects of associated counseling and was intended primarily for use in prisons
and needle exchange program sites. In addition, a project that included both
counseling and support for HIV-infected drug abusers was sponsored in late

1999 by the Ministry of Social Affairs and Health. Another project,
coordinated by the A-Clinic Foundation in collaboration with infection risk

counseling centers, the National Public Health Institute, the National Research
and Development Center for Welfare and Health (STAKES) and the Ministry

of Social Affairs and Health was launched in 2000 to follow up risk behavior

among injection drug users. The Deaconess Institute in Helsinki opened the
Kluuvi service center in 2000 to provide specialized services for HIV infected

drug users. The center provides both daytime activities and short-term
accommodations and hopes to soon provide long-term support housing

services. The center currently serves about 50 clients per day (STAKES

2001).
The use of harm reduction practices in Finland, while generating much
debate, have assumed a more widely acknowledged position as a component

of drug treatment. One such example would be the development of infection
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risk counseling in addition to the substitution therapy and maintenance

treatment system. An ongoing three year experiment in Finnish prisons,
though in its’ early stages, has produced several well-designed instruments for
prison drug treatment and the after-care of released prisoners in conjunction
with field organizers (STAKES 2001).

Drug demand reduction in Finland involves a broad range of activities
and authorities, organizations, citizens and the private sector. Their work is
carried out on the local, regional and national level within the framework of

international cooperation. Drug demand reduction, in particular prevention,

legislation and relevant social and health services falls under the jurisdiction of
the Ministry of Social Affairs and Health. The state provides individual

municipalities with program resources from a central base which allows the

government the opportunity to exercise a degree of control over the planning
of drug abuse services. However, Finnish municipalities are given extensive

autonomy and are responsible for providing intoxicant abuser services and
temperance work by law. Civic groups have a long-standing tradition in
Finland of complementing the public systems. Drug use prevention work is

done by several non-profit and public health organizations specializing in

substance abuse services (STAKES 2001).
Issued at the end of 1998, the Government Decision-in-Principle on

Drug Policy contained a draft proposal for a drug research program. The
conclusions of the Decision were that in order to combat the distribution and

use of drugs, general sociopolitical measures were necessary in addition to
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specific drug demand and supply reduction activities. Demand reduction was
divided into prevention, treatment and support for both abusers and their

families. The Decision was clarified on October 5, 2000 by a second

Government Decision to enhance drug policy (STAKES 2001).
According to the 1998 Government Decision-in-Principle, drug demand
reduction can best be promoted by influencing the population’s living
conditions through the pursuit of the Nordic welfare policy and through early

and effective intervention in emerging intoxicant problems. This goal may be
achieved through programs that:

Develop new approaches in drug education
Promote early intervention and encourage staff members to intervene
through experience and adequate knowledge of useful working
methods.
Establish a committee which will develop proposals for preventing drug
use among young people and reduce the detrimental effects of abuse.
Launch local projects which will support early intervention in young
people’s problems.
(STAKES 2001
The goal of this strategy is the prevention of substance abuse problems

through a national information and prevention campaign carried out by
regional municipalities. A second goal is to provide Finnish citizens with the
services they need, including the care and treatment of drug abusers. Thus,

the strategy utilizes a two pronged approach of preventing and reducing

substance abuse while minimizing the related social and health harms
associated with drug abuse. However, the protean nature of drug abusers

often makes treatment difficult, thus access to care needs to be flexible. In
order to maximize the effectiveness of drug treatment, the Government
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Decision-in-Principle on drug policy in 1998 has outlined the following
approaches:

=

Referral to treatment will be provided on a 24 hour basis.
The quality of care must be assured throughout the country on an
equal basis.
Detoxification and substitute therapy will be provided to meet
present needs.
The Ministry of Social Affairs and Health will examine provisions of
care for pregnant women who use drugs.
Drug prevention in prisons will be developed to minimize the
recruitment of new users and continued drug use.
Models of action will be developed to prevent the spread of
communicable diseases.
Those subject to police measures will be offered expert help in order
to assess their situation and treatment.
The special needs of drug abusers will be considered in the
development of existing services by intensifying personal training.
(STAKES 2001)

i. DruQ Treatment Pro_QramslAvailability: The care and treatment of drug

abusers functions on the general principle of Finnish social welfare and health

care which provides all citizens with the services they require. Drug abuse
and its related problems increase insecurity and cause harm to other citizens.

Therefore, positive outcomes of care and drug treatment have a favorable
impact on drug and related crimes. Ultimately, continued drug abuse will

result in greater costs to society than provision of care and treatment. Thus,
the effective care and treatment of drug abusers is in the best interests of

society as a whole. Additionally, families of drug abusers are also in need of

support guidance and services (STAKES 2001).

In the Finnish drug treatment system, the development of services for
youth and low-threshold services in addition to related training has been
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emphasized. These services are available at a number of low-threshold day

centers throughout the country. Following an assessment of the client’s
physical, psychological and social condition, these day centers offer temporary
accommodations including meals, a shower, and in some cases, health
services. The immediate needs of the client are met while more permanent
solutions are sought within other social and health services. One of the major

goals is to involve potential clients in the treatment system as early as possible

(STAKES 2001).
In the summer of 2001, a working group appointed by the Ministry of
Social Affairs and Health developed a proposal after evaluating the current

systems ability to meet the needs of drug abusers. In their assessment, the
working group concluded that the existing treatment provisions were not being

met due to an incoherent service system. The seeking of treatment is often
made difficult by the fact that different bodies assess treatment need and

provide related services. They cited many cases where social service
organizations alter the original assessment resulting in denial of treatment due

to a shortage of municipal funds. They established that when treating severe
drug addiction, the primary goal is not freedom from drugs, but a reduction in
substance abuse and the prevention, elimination and treatment of related

health, social and other issues. The group determined that successful

treatment requires individual, sustained, many-sided and systematic service
chains, including outpatient clinics, short-term institutional care, rehabilitation
units, support services and self-help groups committed to by both client and
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provider. Personal service counselors should be appointed in municipalities to
assist those with severe drug problems and to ensure appropriate

implementation and coordination of treatment. The working groups proposal
called for significant changes in the methods, skills, attitudes, resources and

legislation (STAKES 2001).

In 1986, it was established in the Act on Welfare for Substance Abusers

(41/1986) that individual municipalities are responsible for organizing services
for intoxicant abusers in a way that meets their needs. The service system in
Finland is composed of outpatient clinics, short-term institutional care,
rehabilitation units and support services and self-help groups. In addition,

many primary health care social service units address drug problems.

However, the number of these specialized services available to drug addicts is
limited primarily to the area of Helsinki and other major cities. Since 1996,
Finland has had an ombudsman based in non-governmental organizations

(NGOs) working with treatment clients throughout the country (STAKES 2001).
Primary health care providers in Finland offer specialized services for
substance abusers primarily in the treatment of poisonings, illnesses and
injuries associated with drug use along with short-tem detoxification. Both

general and psychiatric hospitals treat severe withdrawal symptoms and cases
requiring hospitalization. Mental health clinics provide outpatient care for
psychiatric illnesses which may include substance abuse problems. In 2000,
the Ministry of Social Welfare and Health designated a special role to
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university and central hospitals in the assessment of medical detoxification,
substitution and maintenance treatment of opiate addicts (STAKES 2001).

There are specialized local outpatient clinics in over 100 municipalities
in Finland and several have contracted services for residents from public or

private service providers. Approximately 46,000 people visited outpatient
clinics for substance abusers while 11,000 used residential treatment services

in 2000. Twenty percent of outpatients and sixteen percent of residential

treatment patients were under age 30. The majority of treatment lasted one
week or less while 20% lasted longer than two weeks and 1.4% lasted three
months or longer. A one day census in 1999 revealed that drug clients

accounted for 20% of patients using outpatient services and 30% of those in
residential treatment (STAKES 2001).
Finland has approximately 30 units with special drug treatment

programs, of which, 13 provide residential detoxification, 18 provide
withdrawal treatment and 18 rehabilitation. Drug treatment periods for

detoxification and withdrawal typically last 2-3 weeks while rehabilitation lasts

2-3 months or longer (STAKES 2001).
The Ministry of Social Welfare and Health issued regulations
addressing the use of substitution and maintenance therapies in 1997, which

were subsequently revised in 1998 and 2000. According to the Orders of the
Ministry (28/1997; 42/1998) and a Decree passed in 2000 (607/2000),
substitution treatment using medicines containing buprenorphine, methadone

or levacetylmethadol may only be provided to patients for whom generally
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accepted means of detoxification have failed. The Decree of 2000 also allows
for maintenance therapy but stipulates that treatment may start only when it is
imperative to reduce the negative effects of drug abuse on the patient. This
includes those who are unlikely to stop using drugs but may benefit from
maintenance treatment and avoid contracting communicable diseases or other

negative health effects. Those whose quality of life can be improved and can
be trained for a more demanding rehabilitative substitution treatment may also

qualify. Levacetylmethadol has yet to be employed as its sales authorization

was cancelled in 2001 (STAKES 2001)
Criteria for medical detoxification treatment was established in 1999 at

the Drug Detoxification Unit of Helsinki University Central Hospital and
included the patients age (18 and over), diagnosed opiate dependence (ICD-

10 or DSM-IV) and drug screening to detect recent drug use (naloxone test).

Disqualification from detoxification included uncontrolled polydrug use, acute
alcoholism, psychological or somatic illnesses which preclude treatment and

pregnancy. Criteria for methadone substitution treatment in the Greater
Helsinki area has historically been age (20 and over), compulsive use of

opiates (minimum of 4 years), and a history of institutional or long-term care.

Disqualification from treatment has been brought about by uncontrolled

polydrug use, severe psychological or somatic illnesses which preclude

treatment and acute alcoholism (STAKES 2001).
The working group charged with developing a treatment system for

drug abusers has stated the need for additional resources in order to provide
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treatment for some 1,000 opiod-dependent clients on an annual basis.
Additional monies will also be needed to provide treatment for users of other

drugs (STAKES 2001).

On October 2, 2001, another working group proposed actions to
increase the availability of medicinal treatment of opiod-dependent clients.

The report included methods for increasing treatment options based upon
existing regulations and new regulations that will help meet current
requirements. The present system in Finland does allow for the expansion of
medical treatment services such that all central hospitals provide treatment or

be in a position to do so. Under the present system, treatment begins on a
low-threshold basis whereby the patient is transferred as soon as possible for

follow-up care in a different unit (STAKES 2001).
The working group has also suggested that the Ministry of Social Affairs
and Health could issue a Decree on the organization and implementation of

substance abusers treatment with medicines under the Act on Welfare for

Substance Abusers. This would provide greater flexibility in the
implementation of treatment for opiod-dependent clients than is currently
provided in the existing Governmental Decree. The group feels that a revised

Decree should authorize hospitals, health centers, A-Clinics and other
substance abuse outpatient or in-patient units as well as health care units in

prisons to start detoxification with buprenorphine provided they have received
sufficient training. All substitution and maintenance treatments would be

reported anonymously to a central board, which would provide nationwide
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supervision. The transfer of buprenorphine treatment to primary health care
facilities should allow for more comprehensive implementation of methadone

therapies. In addition, the group suggests a pilot project to assess the efficacy
of treatment provided through private physicians with medicines supplied by

local pharmacies (STAKES 2001).

It is hoped that the proposals of the working group will increase the
availability of treatment without an adverse effect on quality. Recent
information on the effectiveness of buprenorphine should justify a revision in

the regulations that currently limit its use and put Finnish regulations more in
line with those of other nations such as the United States, Australia and

France (STAKES 2001). The Federal Drug Administration (FDA) of the United
States approved the use of both buprenorphine and buprenorphine-naloxone
for heroin addicts in October 2002 (NY Times 2002). Currently, it is not

uncommon for opiate addicts in Finland to travel abroad, especially to Paris to
acquire buprenorphine. The National Agency for Medicines has issued

regulations (3/2000) which limit the import of buprenorphine to 14 days

personal use (STAKES 2001).
ii. Sociopolitical Environment in Finland: The increasing number of written

correspondences to the Finnish government in 2000 and 2001 reflect a
growing national concern over the drug problem. The most common themes
addressed to Parliament include drug treatment, drug-related crime and

resources devoted to anti-crime activities, the spread of infectious diseases
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associated with drug use, drug testing, drug use prevention (especially

directed at young people) and mothers with drug problems (STAKES 2001).

These themes have generated much public debate along with
legislative reforms. In 2000, a Decree was passed concerning substitution
and maintenance treatment and during the summer of 2001, a working group
appointed by the Ministry of Social Affairs and Health addressed the issue of

resources for drug treatment. The group submitted a memorandum
expressing a desire to amend legislation and augment resources for drug

treatment activities (STAKES 2001).
Throughout 2001, there has been much ongoing debate over the
inadequate resources of the police, customs and the frontier guard and the
repercussions on the prevention of international drug trafficking. Infectious
diseases associated with injection drug use have been widely discussed in

light of the HIV epidemics in nearby Russia and Estonia. An effort has been

made to develop legal reform concerning mandatory drug testing in

conjunction with the Act on the protection of privacy in working life, but it has
been forwarded to a special working group which was expected to tackle the
issue by the end of 2001 (STAKES 2001).
iii. Programmatic Details" HIV testing is mandatory for blood donors but

voluntary for all others. Diagnosed H IV infections are recorded in a national

HIV case reporting system using an identifying code. Data on HIV also comes
from screening programs. Surveys on pregnant women have been conducted

nationally since 1993 (WHO 2001).
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The total number of HIV tests performed, excluding unlinked

anonymous testing and testing of blood donations, (1997-2001), and rate of
testing per 1000 population (2001):

1997:

88,181
1998:149,939
1999:130,505
2000:143,490
2001: 145,000

Tests per 1,000 population/habitants in 2001" 28.0
(European Centre for the Epidemiological Monitoring of AIDS 2002)

C. Norway
The Norwegian strategy for combating drug abuse was outlined in

documents developed by the Ministry of Health and Social Affairs in 1991-92.
The documents, entitled Measures Directed at Drug Addicts provides for the

development of a rehabilitation sector and a framework for the organization of

treatment. It also provides for intervention measures, a division of
responsibility and the establishment of regional centers of competency which

focus on the field of drug abuse (SIRUS 2001).

A later report entitled The Drug Policy which was put forth in 1996-97,
describes the development of the drug situation and presented goals and

measures. The need to strengthen prevention work, collective assistance and
rehabilitation, along with an expansion of the restrictive legal drug policy

already in place were emphasized. The goal of a drug-free society was to be

upheld as a necessary expression of the government’s attitude towards drugs

(SlRUS 2001 ).
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The Ministry of Health and Social Affairs presented an action plan in

1998, which was initiated under a backdrop of increased alcohol abuse along
with research showing illegal substances were gradually gaining a foothold
with Norwegian youth. The plan defined areas for intervention and contained

strategies that would ultimately strengthen measures directed at prevention
and public opinion. The primary goals of the plan which address drug abuse

are as follows:
Reduction of the abuse of illegal substances among youth and young

adults.

Increase awareness of the links between the use and abuse of various
substances.
Strengthen negative opinions regarding drug use.
Better and more effective treatment, low threshold health service and
treatment alternatives for drug addicts, including pregnant women and
those with children.
(SIRUS 2001)

To achieve these goals, the state must establish"
Cooperation with homes, schools and leisure time activities within the
framework of building public opinion.
A broad mobilization of volunteers, organizations and youth groups.
Allow municipalities, local pofice and local communities to play a
meaningful role in prevention.
A long-term perspective on prevention.
Directed measures towards entire populations and high-risk groups.
That rehabilitation and treatment measures operate in cooperation with
voluntary organizations, groups and individuals.
Strong after-care services.
(SIRUS 2001)

Out of this action plan came the establishment of a drug policy panel
that was to act as a reference group for the Minister of Social Affairs until

January 1, 2001. The panel provided a bridge between authorities and labor
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groups, the business community, the insurance industry and organizations
working on drug policy. During 2000, a reorganization of the state intervention
in prevention was conducted aimed at strengthening local and regional work

and prevention measures. The reorganization was expected to produce and

spread knowledge and information within the drug abuse field and the creation

of more effective administrative practices (SIRUS 2001).
The primary result of this reorganization was the creation of the
National Institute for Alcohol and Drug Research (SIRUS) on January 1,2001.

SIRUS has the responsibility of conducting research and disseminating results
and documentation on drug issues, with particular attention to aspects of
social science. Research has been divided into five principle areas" drug

markets, drugs and drug culture, prevention, consequences, rehabilitation and

care (SIRUS 2001).
The reorganization of 2000 has given birth to Norway-Net, a collective

of seven regional centers for drug competence. These regional centers are
responsible for increasing competency levels and spreading knowledge within
the drug abuse field among health care and social workers. In addition, the

centers are charged with up grading the drug education levels of key
employees of municipalities and to further develop specialized services for
drug users and to provide schools with prevention assistance. The centers
are to provide the Ministry of Health and Social Affairs with advice concerning
the expansion of national drug policy (SIRUS 2001).
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Recently, the Norwegian government has earmarked funds for lowthreshold services to 14 of the country’s municipalities where the largest
number of drug-related deaths have been recorded. These services target

drug abusers, who for various reasons do not seek help from established
health care centers. Drug addicts are provided with access to doctors and

nurses who provide general health check-ups, treatment for abscesses,
hepatitis vaccinations, x-rays to confirm TB, assistance with hospital
admittance, referrals and accompaniment to both municipal and private health

care centers (SIRUS 2001).
The "Pro Center" in Oslo provides outreach work in known areas of
prostitution with the goal of health education and prevention. Non-

governmental organizations (NGO’s) such as the Salvation Army and the
Church City Mission run low-threshold services for drug abusers, including
shelters, soup kitchens, food and clothing distribution, etc. Strax-house in

Bergen offers services to women over 18 with a history of heavy drug abuse.
They provide shelter for acute cases, a day center, evening and night-time
services and follow-up care. The Socio-Medical Center in Tromso is a

cooperative project with services provided by municipal, county and university

agencies (SIRUS 2001).

In response to the high risk of HIV/AIDS from needle sharing, the city of
Oslo established the AIDS information bus in 1988. The bus provides access

to clean needles, condoms and information about risk factors associated with
injection drug use and HIV/AIDS in an effort to reduce the high-risk behaviors
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seen in this population. Recently, several municipalities have begun to
distribute needles from vending machines and through pharmacies

(SIRUS

2001).
In 1995, an epidemic of Hepatitis A and B broke out arfiong drug
abusers in Norway. However, the National Institute of Public Health in Oslo

closely monitored the situation and took immediate action. Local health
authorities were advised to initiate preventive measures which included"

Cooperation between primary health care, social
services, prisons and drug rehabilitation centers
Information to the drug abuse community regarding
outbreaks, symptoms, modes of transmission, personal
protection and immunization.
Access to clean syringes and other disposable
equipment.
Immunization against hepatitis A and B.
(EpiNorth 2000)
Vaccines against hepatitis A and B were provided free of charge to all

drug users. The cost of vaccination was covered by the National health
Scheme. The cost of clean syringes and information campaigns was covered

by local health authorities. Thus, the national and local surveillance and
prevention programs, which remain in place, successfully controlled the
outbreak of hepatitis A and B (EpiNorth 2000). This is an empirical example of

successful harm reduction.
i. Drug Treatment ProramslAvailabilitv: According to section 3-1 of the

Social Services Act of Norway, municipal social services have an obligation to

sustain efforts to prevent and combat substance abuse. In addition, according
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to section 6-1, municipalities have a comprehensive responsibility for the care
and treatment of substance abusers.
Section 6-1 states:

"By means of advice, guidance and practical assistance, cf. Sections 41 and 4-2, the social services shall help individuals to stop abusing alcohol
and drugs. Advice, guidance and help shaft likewise be given to families of the

persons in question."
"When necessary and when the client so wishes, the social services
shaft provide for a course of treatment. Such a course of treatment may

among other things comprise the appointment of a support contact, the
establishment of a support network at work, and contact with the primary

health services or specialist services."

"Should such assistance outside institutions prove insufficient, the
social services shaft provide a place in a suitable institution for care and
treatment, if the need for such a place at an institution cannot be met, the

social services shaft if necessary see that temporary measures are adopted."

"The social services shaft follow up the client through the course of

treatment in conversations and if necessary on home visits, and by making

arrangements for the measures required on the termination of a stay, if any, at
an institution."

(SIRUS 2001)

According to section 7-1 of the Social Services Act, the counties of

Norway are responsible for establishing and running institutions with specialist
services associated with them for the care and treatment of alcohol and drug
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abusers. These institutions may be county-owned facilities or they may enter
into an agreement with private institutions, psychiatric hospitals, departments

of social medicine and child protection services. Ultimately, the responsibility

for specialized services will fall under the new Act on Specialized Health
Services (SIRUS 2001).

Norway has developed a wide array of treatment and rehabilitation
services using various professional and ideological approaches. Treatment

alternatives range from professional psychotherapeutic approaches to more

simplistic methods based upon a central Christian message. Open psychiatric
alternatives consist of child and youth psychiatric clinics, open social medicine

clinics and a youth psychiatry team. The approximately 70 child and youth

psychiatric clinics offer youths under the age of 18 treatment alternatives for all

types of mental illness. Some of the approximately 100 adult clinics found
across the country employ personnel dedicated to working with drug abuse
and mental disorders. The 28 nationwide youth psychiatric teams concentrate

on working with individuals between 15 and 30 with both drug abuse problems
and psychiatric disorders (SIRUS 2001).
The Social Services Act sets forth the legal provisions for the

compulsory treatment of drug addicts in Norway. These provisions have also
included pregnant drug abusers since 1996. Section 6-2a provides that a

pregnant drug or alcohol abuser can, without her consent, be admitted to an
institution and be detained there throughout the pregnancy, provided the

abuse is of such a nature that it will in all probability have a harmful effect on
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the child, and provided that voluntary assistance is not sufficient. The goal of
this practice is to prevent or limit the likelihood of harm coming to a child, by

offering the pregnant woman satisfactory help for her drug or alcohol abuse
while enabling her to care for her child during her stay in treatment (SIRUS

2001).
Drug treatment in Norway is mostly voluntary, but the law allows for the
holding of an addict in an institution for up to 3 months upon the
recommendation of the County Council for Social Cases. Those who submit

to treatment voluntarily may enter into agreement which allows them to be
held in treatment for a maximum of three weeks. Compulsory treatment is

employed with the intention of encouraging the client to continue further

treatment (SIRUS 2001).
Institutes with 24 hour services, of which two-thirds are in private

hands, consist of minimal intervention facilities up to large institutions.
Organizations such as Kirkens bymison, Stiftelsen Pinsevennenes

Evangeliesenter, Blue Cross, the Salvation Army and others help supplement
the public institutions. These facilities are generally open to anyone with

alcohol, medication or drug problems. Emergency and detoxification
institutions provide drug detoxification and referrals to other rehabilitation
services. In addition, there are a number of purely care-related measures
which accept chronic drug abusers who demonstrate little potential for

rehabilitation. They offer these individuals general care and a drug-free
environment (SIRUS 2001).
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Up until the mid 1980s, the broad consensus among politicians and
drug treatment workers was that methadone therapy should not be used to
rehabilitate drug abusers. However, with continuing reports on the

deteriorating state of chronic users and the rise in drug-related deaths, officials
have reconsidered methadone treatment. A maintenance trial using

methadone conducted in Oslo in 1991 on HIV-positive clients with long-term

immunodeficiency generated little negative criticism. Ultimately, debate
centered on whether methadone therapy should be made available
independent of H IV status. Opponents feared that methadone therapy would
be interpreted as a sign that drug abusers are considered hopeless victims of
their own abuse (SIP, US 2001). Proponents countered that methadone could

save drug abusers from humiliation and an early death while improving their
quality of life (Skretting 2001).

A three-year methadone-assisted trial project was initiated on 50 opiate
addicted drug users in Oslo in 1994. The program was based upon the
Swedish model which carries strict admission criteria, including opiate

addiction for a minimum of ten years and being over 30 years of age. In June

1997, the Norwegian Government established the development of a national
methadone program. The target group consisted of drug abusers for whom

progress had remained elusive with other forms of treatment. The primary
emphasis of the program was rehabilitation combining efforts to improve the

clients’ standard of living along with medical treatment. Criteria were re-

evaluated in 2000 and are currently less restrictive. Potential clients must be a
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minimum of 25 years of age and heavily addicted to opiates for several years

despite a reasonable amount of treatment (SIRUS 2001).

A national treatment center has been established in Oslo with regional
coordinating agencies spread over four health regions. The treatment plan is

based on cooperation between social centers and physicians. The potential
client applies for admission through local social centers. Application must

include an action plan outlining individual goals and necessary measures. In
addition to methadone, Subutex, or high-dosage buprenorphin has also been

approved for use. Trials using LAAM, a methadone-like medication with a

longer half-life were performed in 2001 (SIRUS 2001). The program has
expanded rapidly and was expected to service 1,600 clients by the end of
2001 (Waal et al. 2001)
The proportion of prison inmates serving time for drug use has
been growing, but is thought to reflect only a microcosm of the drug problem in
the general population. Prison authorities report some 40

60% of inmates

use drugs at least once while in prison. Despite strict controls, there are large
numbers of injection drug users in the prison system. Thus, drug use, along
with the associated problem of H IV/AIDS presents a major problem for the

Norwegian prison system. A major goal of the prison system is to provide both
prison staff and inmates the greatest degree of protection with respect to HIV

exposure. In an attempt to prevent the spread of HIV and related diseases,
the State Health Authority has required prisons to make bleach available for

the cleaning of used needles. However, there are no clean needle distribution
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programs in the Norwegian prison system. Substitution therapy is made
available to inmates who have already begun treatment so they may continue

therapy while serving out their sentence. Substitution therapy may also be
made available at the beginning of a sentence should the inmate satisfy

program requirements (SIRUS 2001).
ii. Sociopolitical Environment in

Norway: Currently, the "general

consensus" among drug abuse experts, politicians and the general public is
that any measures leading to the liberalization of drug laws should be rejected.

Despite the sharp increase in the use of cannabis and amphetamine type
stimulants, the vast majority of young people under the age of 21 oppose the

use of illicit drugs (SIRUS 2001).

Although there has been minimal debate within the legislature, criticism
has been raised against the existing drug policies of Norway. In recent years,
the media in particular has focused in on the dramatic rise in the number of

drug- related deaths and has called for more effective measures to limit drug
associated mortalities. Critics often point to what they see as an uneven

balance between the legal framework and the seriousness of the crime.

Sentencing for non-drug related criminal behavior in Norway is considered
mild, while the level of punishment for drug-related crimes is considered harsh.

Additionally, citizens and attorneys have raised doubts regarding the
effectiveness of the current penal system with respect to preventing drug

abuse. Some in Norway have questioned whether the current restrictive drug
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laws are counter-productive, in that they may lead to prison overcrowding and
associated problems, such as the spread of infectious disease (SIRUS 2001).

It is generally viewed in Norway that harm-reduction measures directed
at reducing the negative effects of drug abuse towards the abuser, their
families and society as a whole are compatible with the general goal of

treatment as full rehabilitation. However, the need for additional harmreduction measures is seen as somewhat controversial, in particular, the
establishment of public injecting rooms in protected environments. Before its’

resignation in October 2001, the former Government concluded that public
injecting rooms could be legally established in a limited number of
municipalities on a trial basis. The new Government is awaiting commentary

on the proposal before it acts (SIRUS 2001).
The issue of substitution therapy also remains controversial among
both those seeking treatment and the drug rehabilitation community. Since
the conclusion of a pilot study in 1997 involving 50 clients, the number

receiving substitution therapy has risen significantly and was estimated to
reach 1,600 by the end of 2001. Government investment in substitution

therapy in Norway is based on the moral duty to improve the lives of those
suffering as a result of chronic drug abuse. The viewpoint is that substitution

therapy does not ignore the ethical dilemmas associated with replacing a lifelong addiction to one narcotic drug with another. Norway has been funneling
increasing resources into substitution treatments primarily due to the fact that
other rehabilitation programs have generated limited results (SIRUS 2001).

iii. Programmatic Details" In Norway, HIV testing is systematic for blood

donors, pregnant women and patients with sexually transmitted infections

(STI). Diagnosed HIV cases are reported in a national HIV database which
utilizes an identifying code (WHO 2002).

The total number of HIV tests performed, excluding anonymous testing
and testing of blood donations, (1997-2001), and rate of testing per 1,000

population (2001):

1997:189,369
1998:194,771
1999:196,395
2000:175,002
2001:172,960

Tests per 1,000 population/habitants in 2001" 38.6
(European Centre for the Epidemiological Monitoring of AIDS 2002)
Vl. Discussion

A. A Contrast in Policy and a Growing Problem
This section will contrast the drug policies of Finland and Norway with

those of the Russian Federation. The overall approach to supply and demand

reduction on both a national and local level will be addressed in each country.

The increase in drug experimentation along with related harms seen

throughout the decade of the 1990’s led to increasing concerns over the
question of drug abuse in Finland. In response, an inter-administrative
committee was launched in 1996, charged with creating a national drug

strategy. A proposal was developed in early 1997 which ultimately led to the

Government’s Decision-in-Principle on Drug Policy in late 1998. Both
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documents followed the recommendations of the United Nations by completely
endorsing a well-balanced approach to drug policy. The drug strategy
proposal initiated regional training in local municipalities that led to the

planning of drug strategies assigning equal weight to both supply and demand
reduction (STAKES 2001).

On a national level, the Decision-in-Principle resulted in a proposal for a
drug research programme for the Academy of Finland in 1999. Additionally,
local drug research programs composed of working groups charted new drug

cultures among young people. Data compiled by these groups was used to
plan preventive measures and proposals for developing drug treatment

systems. Concerned Ministries included drug topics in their financial and
action plans (STAKES 2001).

A joint meeting between the Academy of Finland and the Finnish
Medical Society Duodecin convened in late 1999 to further develop a drug

treatment plan. The outcome of the conference centered on a need to
promote drug treatment and research. Similar approaches arose from working

groups on young people’s drug prevention (2000) and drug treatment (2001)
under the auspices of the Ministry of Social Affairs and Health. In addition,
both the police and prison officials have produced their own drug strategies in
line with the 1998 Decision-in-Principle, with demand reduction receiving equal

consideration to supply-side measures (STAKES 2001).

The government of Finland has determined that drug use and related
harms warrant a broad, multi-administrative national plan based upon the
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1998 and 2000 Government Decision-in-Principle on drug Policy. The 2000
Decision enhanced the efforts of the 1998 Decision while providing for a

supplementary budget for drug work. The primary objective of the 2000
Decision was to reduce both the supply and demand for drugs and to slow the

growth of drug related crime. It proposed an action plan to integrate the anti-

drug focal points of various agencies (Justice, Interior, Finance, Education and
Social Affairs and Health) and allotted an additional 5.5 million (EURO),

increasing the 2001 budget to 10 million (EURO) for drug control (STAKES

2001). The main components of the 2000 Decision included"
Anti-drug attitudes in society will be reinforced by targeting
preventive drug information at the entire population
Drug addicts will be given better possibilities for treatment and
rehabilitation
Drug offenders’ risk of getting caught will be increased; an
effort will be made to ensure criminal liability in drug crime;
and anti-drug work in prison will be promoted.
(STAKES 2001)

In conjunction with the long-term plans outlined above, actions have
been undertaken to solve current drug problems on both regional and local
levels as well. Prevention has been focused on the life management skills of

young people through the use of the media in combating drug use and early
intervention in drug experimentation. A network of municipal coordinators

provide drug training for prevention workers and plans exist for a nationwide

drug information campaign subject to broad-scale evaluation (STAKES 2001).

On a national level, emphasis has been placed on enhancing the flow
of information between components and increasing the availability of existing
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data. Services have been developed to disseminate information among drug

workers regarding research results, working methods, municipal drug
strategies and anti-drug projects advanced by municipalities and other
organizations. Telematics services in drug work, including drug information
services, discussion forums and anonymous self-testing through the use of

text messaging on mobile phones have also been developed. However,
proposals involving mass screening for drugs have generated much public
debate (STAKES 2001).
The development of treatment services for Finnish youth and lowthreshold services in the treatment sector have been emphasized with the aim

of involving clients in the treatment system as soon as possible. In addition,
the position of harm reduction in treatment has gained wider acceptance,

including the development of infection risk counseling as well as substitution

and maintenance therapy systems (STAKES 2001).
Rehabilitation for substance abuse has been ongoing in Finnish prisons

for approximately ten years. A three-year experiment begun in 1996 and

ended in 1999 has resulted in effective drug treatment in prison and after-care
for prisoners upon their release. The project produced a total of ten
rehabilitation and training programs for use in prisons. Currently, rehabilitation

for substance abuse is based upon structured handbook programs produced
from a cooperative effort between the prison Administration and organizations
in the field of drug abuse. The majority of these programs are based on

several theoretical models, including cognitive behavior therapy, solution-
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oriented approaches, community treatment or the twelve-step program.

Generally, these programs involve a period of rehabilitation two to three times

per week, life management skills, work and/or work training and learning to
develop hobbies all of which support a drug-free lifestyle. Being
multidisciplinary, prisons provide an excellent environment for the teamwork

approach necessary to prevent relapse (STAKES 2001).

As in Finland, drug policy in Norway is based on a comprehensive,
multidisciplinary approach. Demand reduction efforts such as prevention,

treatment and rehabilitation are equally balanced with, and designed to
reinforce, supply side measures. Throughout the decade of the nineties, the

Norwegian government has increasingly emphasized the importance of

developing a comprehensive "substance abuse policy", with regard to
prevention, care and treatment. The pragmatic implementation of the national

drug policy is focused equally on demand and supply reduction, primarily

through prevention (SIRUS 2001).
There has been a significant increase in the quality and extent of
research results concerning substance abuse in Norway over the previous two

decades. Thus, the Government of Norway has lent increasing support to

efforts that seek to obtain knowledge in the substance abuse field and in turn,
raise the level of competence among drug abuse professionals. With the

challenge of increased access to and availability of illicit drugs, the

government of Norway has made substance abuse policy a major priority

(SlRUS 2001).
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Since illicit drug abuse became a social problem in the 1960’s, Norway

has pursued a restrictive drug policy. The increase in drug possession and

trafficking has led to discussions concerning the value of a restrictive
approach. However, a government report released in 1996-97 clearly stated
that liberalization would imply that society no longer considers drug abuse a
serious problem. This would lead to an increase in the availability of drugs

and consequent increase in abuse. The "Government declared that the
ambitious goal of a drug-free society would be firmly upheld, as a necessary

expression of attitude towards drugs (Innst.S.nr40 1998-99)." The

Government also stressed that greater emphasis must be placed on
prevention, not the least of which to be carried out within the framework of

NGO’s. The goal is to reinforce negative attitudes towards drugs through
prevention (SIRUS 2001).
The primary responsibility of drug policy, that being prevention, care

and treatment, lies with the Ministry of health and Social Affairs. The

multidisciplinary nature of drug abuse has led the Ministry to appoint a drug
policy panel to analyze the drug problem and coordinate specific aspects of

drug policy. The national drug prevention field has recently undergone
reorganization. This was done primarily to increase support to local
communities, strengthen after-care programs and ensure broad and current

access to knowledge and experience as a basis for strategic planning and
policy development. Additionally, the reorganization was intended to

strengthen research and education within the drug field. Beginning January 1,
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2001, three central components of drug abuse prevention; research and
documentation, education and competence and administrative tasks under

went the following reorganization"
The National Institute for Alcohol and Drug research (SIRUS)
The Norway-Net consisting of seven regional centres of

competence
The remaining Norwegian Directorate for the prevention of
alcohol and drug problems.
(SIRUS 2001)

Based on guidelines supplied on a national level, municipalities are

responsible for both prevention and rehabilitation of substance abusers. The
belief is that services should be anchored in the local communities where

problems exist. Treatment is based primarily on the basis of voluntary, drug-

free rehabilitation. Additionally, measures should be designed to meet the
special needs of clients, such as pregnant drug abusers and those with
children. Low threshold services are also given added priority (SIRUS 2001).

Substitution treatment for IDU’s has been available on a national level
since 1998. Therapy is provided in specialized regional centers, but municipal

health and social services are responsible for follow-up. A major effort has

been made to clarify issues of organization, responsibility and financing in
order to alleviate confusion among local doctors and social services. A
revised model integrating substitution therapy into municipal health and social

services was implemented in July 2001 (SIRUS 2001).
Substitution therapy using methadone and/or buprenorphin has become

well established in Norway using a well functioning, regionally based
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professional model with municipal and county cooperation. Opposition to
substitution therapy is gradually being replaced with a consensus on the

positive and negative aspects of treatment (SIRUS 2001).
Criminal care facilities in Norway work diligently to direct inmates to

correctional programs addressing their problems with drugs. Both during and

after serving sentence, prisoners are provided with opportunities to participate
in various programs dealing with dependency. These programs include, but

are not limited to:

Contract sentences
An alternative sentence in accordance with paragraph 12"
of the prison law
Drug dependency programs
Life mastery programs
The establishment of networks
Probation groups
Work experience within an institution
Education
Leisure activities
Participation in the prison system’s work-furlough program
(SIRUS 2001)

(*Prison law 12 provides that inmates with a drug problem may elect to
be transferred to a treatment facility that meets the specific needs of the
inmate. The law specifies that mitigating circumstances be present if
the convicted person is to serve their entire sentence in a treatment
facility.)
(SIRUS 2001)

Criminal care services also cooperate with a number of humanitarian,

religious, sports, cultural and drug prevention organizations. These groups

promote improved self-esteem and integration into leisure activities through
outreach work and measures that promote various skills. Attention is given to
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building and maintaining networks that help individuals establish themselves in

drug-free environments before release (SIRUS 2001).
The development of HIV/AIDS has presented a major challenge for the

prison system. It has been critical to ensure the greatest degree of protection
with respect to HIV exposure for both inmates and prison staff. Intravenous

drug use is relatively common in Norwegian prisons (it is estimated that 40-

60% of inmates use drugs) despite strict controls. In an effort to prevent the
spread of disease, the State Health Authority has required prisons to make
chlorine bleach available for the cleaning of needles. However, there are no

needle distribution programs in Norwegian prisons (SIRUS 2001).

Access to substitution therapy is provided to inmates that have already
begun such treatment. In addition, inmates that fulfill admission criteria may
begin substitution therapy while in prison (SIRUS 2001).
Since the breaking up of the Soviet Union in 1991, the Government of

Russia has focused increasing attention on the expanding illegal drug trade in

the country. Numerous measures have been taken both internationally and

domestically to slow the rapid increase in illegal drug use. However, Russia
has neglected the balanced approach to illicit drug abuse recommended by

the United Nations. Current drug policy focuses primarily on supply side

measures with little in the way of provisions or finances for demand side
measures such as prevention, treatment and rehabilitation (MPI 2000).

Dr. Vadim Pokrovsky, Director of the Russian Federation AIDS Center
estimates that as much as $65 million (US) is needed immediately to slow the
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spread of HIV and to treat those already infected with HIV. However, the
Russian

Government budgeted only $5.1 million (US) for 2002 to combat

HIV/AIDS. The Russian Government failed to submit a proposal to a new

global AIDS fund which could have supplied as much as $27 million (US).
Alexander Goliusov, Head of the Russian Health Ministry’s HIV Infection and

Treatment Department said that "while Russia contributed to the fund, we
chose not to request aid like Ukraine, which like a beggar, has stretched out a

hand for help" (Rodriguez 2002).

The fight against illegal drug use has been guided primarily by the
Russian Criminal Code put into effect in 1997 and the Federal Law on Narcotic

Drugs and Psychotropic Substances of 1998. The restrictive policies of these
documents make it extremely difficult to grant exemption from criminal
responsibility even for the possession of small quantities of drugs. This, in

turn, makes it difficult to assign drug treatment in lieu of time in prison (MPI

2000).
The efforts of Russian law enforcement under these policies has led to

a staggering increase in the number of reported drug offenses to 216,364 in
1999 from 16,255 in 1990. However, most of the recorded offenses (82.5%

from 1990-1999) concerned drug users with no intent to distribute. Analysis of
judicial sentencing shows that most of the individuals arrested and prosecuted

for drug offences in Russia on a yearly basis are drug users, not dealers.
According to Galinsky and Zobnev, 1998,
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’the police prefer to arrest drug users rather than drug distributors
because it is easier to do so. For the same reason, they prefer to detain and
transfer to the courts mostly cases of addiction to narcotics, not the distributors
of narcotics’;
(MPI 2000)

Many drug users are arrested and convicted for the "acquisition and
keeping without purpose of sale of narcotic drugs" because the meaning of

"large scale" established by the Standing Committee is so very low. The
Research Institute of the Prosecutor General’s Office (RIPGO 2000) has

presented data which supports the fact that,

"It must be admitted that in most cases the growth of drug offences is
caused by the registration of drug users’ offences. This practice existed even
earlier and it goes on up to now. Nevertheless, the criminal prosecution of
drug users does not solve a problem, but, indeed, produces a worsening of the
general situation. The vacant places of convicted drug users are rapidly
occupied by new people and drug dealers multiply their profits and proceeds."
(MP12000)

Thus, it appears that the primary targets of law enforcement and often
police repression are drug users and petty dealers, those who do not pay the
krisha, (protection tax) to police officers and other high-ranking officials (MPI

2000).
Anecdotal reports from drug users in Russia state,

’the law enforcement agencies detain either drug users or petty
dealers, they make no effort to catch people involved on the upper levels of
the drug distribution chain. For this reason, it is too early to say that the fight
against drug trafficking goes on already" (MPI 2000).
’the impression that the police ’close their eyes’ on the retail and
wholesale distribution of drugs. The corruption of law enforcement is
widespread. In order o fulfill a target’, sometimes they look for an addict,
maybe put heroin on him, and then arrest him. It is nearly always possible to
buy one’s freedom. Indeed, they frequently put drugs on you, just to get the

money" (MPI 2000).
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The fear of those working for public drug treatment centers and NGO’s
is that restrictive drug laws and the focus of law enforcement on drug users

may discourage users and addicts from seeking treatment. Ludmila
Markoryan (Markoryan 2000), a drug worker, has stated,

"In my opinion, the new drug law does not solve the drug problem and
may, on the contrary, worsen it, since it does not address the reasons of the
spread of drugs, but only its consequences; it does not fight the drug business,
drug trafficking and the drug dealers, but the drug users. As a result of this
strategy, drug users go ’underground’, trying to keep away as far as possible
not only from law enforcement agencies, but also from medical help" (MPI
2000).
A key principle of Russian drug law is the supposed priority on
preventive measures for drug abuse along with the development of treatment

and rehabilitation. Article 54 of the federal drug law states that "the state

guarantees help to drug addicts, including examination, consulting,
diagnostics, treatment, and social-medical rehabilitation." However, due to

budgetary restraints, only a portion of Article 54 has been implemented.
Narcologists, drug treatment providers and the staff at state and foreign run

NGO’s agree that more needs to be done in the areas of prevention, treatment
and harm reduction. A lack of funding has prevented the inclusion of a

provision for the "social and medical help for drug addicts" in Russian law (MPI

2000).
For the most part, state run drug treatment centers have been unable to
deal with the recent explosion in drug use. They lack the "financial, material
and human resources" even to fulfill the tasks charged to them under Russian

drug law. Anecdotal information obtained from drug users in Moscow, St.
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Petersburg and Vladikavkaz report that it is "common practice to pay for
services that should have been obtained gratis." Additionally, the fear of being

reported to authorities keeps many drug users from seeking help at state run

drug treatment centers. Ironically, this leaves many public facilities operating
below capacity. According to Eliko Ciklauri at the North Ossetian Narcological

Center (Ciklauri 2000),
’the technical equipment of the state centres and the supply of medical
drugs are described as very bad by the local Ministry of health, and the heads
of the centres. The quality of treatment is decisively conditioned by these
factors despite the high costs of treatment, which the user must pay
themselves. Most drug addicts simply cannot afford to start long-term
treatment. The consequence is that even the limited capacity of these centres
is not employed. In January, 2000, most of the 20 places for drug users were
not occupied" (MPI 2000).

Though present in virtually all Russian cities, private drug treatment

centers fall woefully short in their attempt to compensate for the flaws of the
public centers. In addition, private centers must operate contra legem, as
Russian drug law clearly states, "medical treatment of drug addicts is done

only in state and municipal health institutions" (Art. 55). Although popular
because they offer the guarantee of anonymity, private facilities remain a
viable alternative only for those able to afford up to $200 (US) per day for

treatment (MPI 2000).
Russian drug law also severely limits drug prevention activities. Most

state institutions lack sufficient funds for drug information and prevention
activities. However, the law prohibits international organizations and NGO’s

from providing these services. Article 46,

133

fforbids all forms of drug propaganda whatsoever; any activity,
performed by citizens or organizations, that spread information about the
production and use of narcotic drugs, psychotropic substances, and their
precursors and the places where these substances are sold. It is also
forbidden to spread and distribute this information in computer networks, mass
media and it is forbidden to spread or distribute books and leaflets with the
above mentioned information" (MPI 2000).

Harm reduction interventions used to inform drug users of the risks
associated with drug use and the teaching of risk reduction strategies are

made extremely difficult under this law. Though many harm reduction

programs have received permission form local city and regional
administrations, many report interference from police. Along with needle

exchange, the Moscow Office of UNAIDS considers these programs vital to
reducing the spread of HIV among drug abusers. Despite the lack of funding,

most experts in the field of drug abuse agree that drug prevention, treatment
and harm reduction should be given at least equal weight to supply side

measures such as drug trafficking (MPI 2000).

B. Analysis of the Situation
This section contains an analysis of the impact of drug policy on the

epidemiological situations in Russia, Finland and Norway. This paper will

attempt to demonstrate cause and effect between the national approach to
injection drug use and the incidence of HIV/AIDS and related infectious
diseases in each of these countries.

Clearly, both Finland and Norway have adopted a well balanced
approach to drug abuse, while the Russian Federation has not. For the most

part, Finland and Norway have chosen to follow the UN guidelines which
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recommend equal attention be paid to demand and supply side efforts, with a

heavy emphasis on prevention and treatment. Despite pursuing a restrictive
drug policy, Norway has not lost site of the importance of including harm
reduction as part of their overall strategy. Both governments have shown to

be receptive to new ideas while actively involved in the research and
education necessary to evaluate new theories and make policy decisions.

Russia, on the other hand, is mired in a draconian approach to drug abuse,

hampered by a lack of organization and funding with a heavy dose of
corruption thrown in for good measure.
With a health care system based on the Nordic welfare policy, Finland

and Norway have effectively controlled both drug use and the incidence of

H IV/AIDS and related infectious diseases. A balanced strategy with equal
resources devoted to both supply and demand reduction has enabled these
countries to check the emerging outbreak of HIV, TB, hepatitis and STI’s

among injection drug users in the late 1980’s. The proactive implementation
of harm reduction strategies, including a heavy emphasis on prevention,

treatment, rehabilitation and maintenance (after-care) has kept prevalence

rates low among IDU’s. Incidence rates of HIV and related disease have been
in decline since 1996.

Despite relatively strict supply side drug policies, the governments of

both Finland and Norway moved quickly to embrace harm reduction strategies

at the first sign of an epidemic of HIV and related infectious diseases in the
mid-1980’s. Both countries commissioned committees to analyze the situation
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and make recommendations to address the looming outbreak. Equally as

important, legislation was rapid and budgets were established to put their

plans into effect. Beginning often as pilot programs in potentially high risk

areas, harm reduction strategies pre-empted a possible HIV outbreak among
injection drug users which has successfully kept incidence rates low.
Prevention based information campaigns sounding the associated risk

of HIV and related infectious diseases among IDU’s quickly sprang up

throughout both countries. Information campaigns targeted wide sectors of
the population including police, school administrators, teachers, psychologists

and other medical professionals and the media. Information about the risk of

HIV was distributed among the IDU population. Syringes and needleexchange programs became widely available along with information regarding
the disinfection of drug use equipment. Voluntary and confidential HIV testing

was made readily available. Treatment centers were established and continue

to expand their role. IDU’s arrested for drug use are given the option of a
treatment facility in lieu of prison. Those completing treatment are provided
with follow up rehabilitation, especially those IDU’s which are HIV positive

(Aavitsland 2001).
The aggressive approach to harm reduction has enabled both Finland

and Norway to keep a potentially devastating epidemic at bay. HIV/AIDS and
related diseases do not limit themselves to the driving population. Eventually,
these diseases will spread to the general population with a potentially dramatic

effect on the health and vitality of a nation.
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However, Finland and Norway have not had to deal with the social
upheaval created by the break up of the Soviet Union as seen in Russia,
which in turn, has spawned an outbreak of injection drug use and related

infectious disease. The dramatic rise in HIV/AIDS among injection users

noted in 1997, which has continued to this day, has gone hand in hand with
the social and economic upheaval associated with the rise of independent

states from the former Soviet Union. The rapid collapse of the Soviet Union
has brought about a systematic transformation rarely seen in recorded history.

The difficult transition from a socialistic to a free market economy has come at

a high social cost. Economic inequality has spread throughout a population
once dependent on the state leading to an overall decline in the standard of
living.

Although discouraging individualism and motivation, the heavily
localized industry of the former Soviet Union at the very least provided social

structure in areas such as employment, education and health care. The fact
that this support system vanished almost overnight has left the public with little
time to make psychological adjustments. Thus far, the private sector has been

unable to compensate for lost production and provide services once supplied

by the government. The burden of providing a social support structure has
been shifted from the state to individuals (DET 1999).
The declining standard of living coupled with a growing list of social

problems has spread to the health care system as well. The decline in Gross
Domestic Product (GDP) has caused Russia to make drastic cuts in health
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care spending. Thus, health policies have been unable to stem the rising tide
of health concerns, including, alcoholism, cigarette smoking, drug abuse and
associated infectious diseases.

In particular, the social upheaval found in Russia has created an
atmosphere conducive to the spread of HIV/AIDS and related infectious
diseases such as TB, hepatitis and other STI’s. Factors such as widespread

poverty, increasing gaps between the wealthy and the poor and subsequent
economic migration have resulted in the disruption of family support systems,

education and health care. The shift in ideology from communism to
individualism has spawned an increase in risk-taking which has translated into

unsafe sexual practices and drug use (DET 2001).

Large increases in the number of children who no longer live with their
parents are a function of the growing disillusion, hopelessness and loss of
purpose among Russian youth. Many have sought respite through criminal
activity or escape through alcohol and drug use. The combination of strong
demand for and easy access to illegal drugs has resulted in a dramatic rise in

drug abuse. Practices associated with drug use including drug preparation
and injecting practices along with rising prostitution has led to the increased
risk of contracting HIV. The socioeconomic crisis has also spawned a
dramatic rise in the prison population which is at great risk of HIV due to sex

and drug use (DET 2001).
The epidemic of HIV/AIDS and related infectious diseases cannot be

blamed solely on Russian policy or the lack there of. Rarely in history has a
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population had to cope with such rapid changes in social structure of a nation.

However, the response of the Russian government to this growing catastrophe
has thus far, been woefully inadequate. The lack of effective legislation has
allowed the incidence of HIV/AIDS, driven primarily by injection drug use, to
increase at a rate unequalled anywhere in the world.

The legal response to the acceleration of drug abuse in Russia has
been to assume a highly restrictive approach with a heavy emphasis on supply
reduction. In 1998, Russia passed comprehensive Federal Law on Narcotics

and Psychotropic substances including the criminalization of the purchase
and/or possession of illegal substances, even without the intent to distribute.

The laws clearly emphasize law enforcement strategies to increase police

powers, especially in the area of trafficking. However, institution of policy
remains difficult in an unstable political and economic climate. Available funds

for demand side measures such as treatment and prevention are minimal at
best. Virtually no programs have been established for prevention and

treatment outside of existing compulsory treatment in under funded

government institutions (Fedworld 2000). Policy decisions and actions taken
in the coming years will ultimately determine if the current epidemic of HIV in

the Russian Federation and other countries of Eastern Europe continues its

explosive growth rate (UNAIDS 2001).
With regard to drug policy, the Russian Constitution has modeled itself

after the United States in an effort to strengthen cooperation with the US.
Much of Russian drug law is prescribed by the US in exchange for financial
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help. The United States has, and continues to encourage Russia to develop a
comprehensive strategy based primarily upon supply reduction. In return, the

US provides funding, training, personnel, equipment, technical assistance and
law enforcement advisors. The emphasis on supply side measures has

brought questionable success in politically and economically stable countries
such as the United States. Employing such strategies in an unstable region
such as the former Soviet Union has only worsened the growing epidemic of

drug abuse and related infections.
Restrictive drug laws coupled with a serious lack of funding has bred

corruption among law enforcement personnel. Fear of the police sends many

drug users "underground" and hinders the few examples of harm reduction
practices in effect, such as needle exchange programs, education, treatment

and rehabilitation.
Russia has struggled with an ineffective criminal justice system since

the break up of the Soviet Union in 1991. Only after a small pilot program in

Moscow in 2002, has Russia instituted jury trials. For example, the Siberian
city of Izhevsk held its’ first jury trial in over 85 years on February 17, 2003

(Wines 2003). Currently, the accused often spend long periods in jail awaiting
trial in a prison system highly conducive to the spread of drug abuse and

infectious disease.

Thus, the tightening of drug laws has yet to quell the explosion in drug

use since breakup of Soviet Union, particularly since 1997. In fact, one might

argue that Russian drug policy has been counter productive in that while
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failing to curtail drug use it has fanned the flame of HIV and related disease.
The explosive growth of substance abuse throughout the Former Soviet Union
has facilitated an epidemic of HIV, Hepatitis, Tuberculosis and STI’s such as

syphilis, gonorrhea, chlamydia and trichomoniasis. Failure to control these
epidemics will surely lead to a second epidemic in the not to distant future

among the non-injecting population through sexual transmission. Recent
evidence of a possible leveling off in this epidemic will likely be offset by a

secondary outbreak among heterosexuals, particularly females. An explosion
in drug use is often followed by an explosion in prostitution as individuals seek

ways to support their habit. HIV and other diseases spread from addicts to
prostitutes and finally to the general population.
This is a tremendous concern not only to Russia and the countries of

the former Soviet Union, but to Border States which include Finland and

Norway. Prevention based programs encompassed in the Nordic Welfare
policy which have kept prevalence rates relatively low and incidence rates

declining may go for naught as disease spreads from northwestern provinces

of Russia into Scandinavia. Immigration for prostitution and search for work

can spread disease which can potentially spread throughout the general

populations of these countries. The potential for such a disaster is real, as
evidenced by the HIV epidemic among injection drug users and sex workers in

the Northwestern territories of Russia.

Many in Russia feel that while they agree drug use is a problem, there
are many more pressing concerns facing their country. Much of Russia

suffers from public disinterest with the drug problem citing "bigger problems",
such as the economy and the ongoing war with Chechnya. However, this may

prove to be a short-sighted approach, which shows a serious lack of
understanding of the new social issues facing the country. The

marginalization of drug users is likely to produce effects on the economy which

may be staggering for years to come as this crisis affects primarily the young

(18-24). World Bank experts forecast economic damage through 2020 based
upon current rates of HIV infection (AP 2002).
The difficult transition from socialistic to free-market economy has

spread to health care as well. One of the most significant social

consequences of the break up of the Soviet Union has been the virtual
collapse of the health care system. While Soviet-era conditions were poor,
marked by uneven standards of care, current problems are more basic. Public

hospitals and clinics lack even the most basic equipment and medicine (NY
Times 2001). The decline in health care is occurring in the face of increasing

rates of infectious diseases as outlined in this paper. Some within the health
care community have speculated that Russia may not be ready for a free
market health care system and would be better off at this point to maintain a
socialistic health care system (Garrett 2001).

VII. Recommendations" A New Approach for the Russian Federation
This section will provide an overview of successful science-based harm
reduction strategies which have been employed throughout the world. It will

then provide a model based upon these strategies which can and should be
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implemented in the Russian Federation to reduce the harm associated with

injection drug use.
There is ample evidence that supply side reduction is ineffective in

quelling substance abuse. Expensive and often counterproductive law

enforcement continues to be the primary international response to illegal drug

use. Reliance upon criminal penalties often results in the violation of the
human rights of injection drug users. These policies eventually lead to poor

health outcomes in this population. The complications of injection drug use,

as alluded to in the previous section, have become more serious. It is
estimated that 5 to 10 percent of global HIV infections are transmitted through
contaminated needles and through sexual contact between IDU’s and their

partners. These figures reach as high as 90% in urban areas and in areas of
the Russian Federation such as the Murmansk and other northwest territories

(Aavitsland 2001). Therefore, HIV prevention and control among IDU’s is
essential to both their health and to control the spread of HIV to the broader

public (Wodak 1998).
Several promising risk reduction strategies have been employed

throughout the world. Ethnographic studies of IDU’s in major HIV epicenters
have demonstrated that drug users who were knowledgeable about the risks
associated with intravenous drug abuse employed behavior changes to reduce

their risks. Conversely, laws and regulations restricting the sale, distribution or

possession of syringes made it difficult for users to obtain sterile syringes

(Needle et al 1998).
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Needle et al (1998) cite over 36 studies reporting significant reductions
in HIV risk behaviors in IDU’s who participated in community-based outreach

programs. Community-based outreach programs are an effective public
health strategy to reach "underground" IDU populations to diminish their risk
behaviors and consequent risk of HIV/AIDS. Since most IDU’s (85%) are not
in drug treatment on any given day, they are at significantly greater risk of HIV

infection since they are more likely to inject drugs and to share drugs and

injecting equipment (Needle, et al 1998).

The hiring and training of indigenous members of a community (mostly
former heroin addicts) to provide outreach to active IDU’s in heavy drug use

areas has been successful in the United States and other countries. Trained,
mobile teams of indigenous outreach workers are able to access, engage and
intervene with IDU’s not in treatment within their own communities. Once trust

and rapport has been established, risk reduction activities can be established
in a neighborhood setting. This intervention strategy enables trained

personnel to reach IDU’s who are either unable or unwilling to access drug

treatment and change their behaviors associated with the risk of HIV/AIDS

(Needle, et al 1998).
Vlahov and Junge (1998) reviewed scientific findings indicating hat
needle exchange programs have substantially positive effects on the

prevention of adverse health consequences associated with injection drug

use, do not promote drug use and do not pose a risk to the non-drug using
public. They concluded that if the legal penalties associated with the purchase
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and/or possession of syringes were removed,

IDU’s would modify their

behaviors to reduce the spread of infection. As a significant number of

needles and syringes are exchanged (and removed from circulation), the

frequency of exchange increases and the circulation time decreases.
Empirical studies have demonstrated that a decline in the circulation time of

needles and syringes is associated with a decline in the infection rate of
returned syringes, a decline in the probability of infection and a reduction in
the frequency of needle sharing among program participants (Needle et al

1998).
According to Heimer, HIV transmission among IDUs is influenced
mainly by four factors: (1) the prevalence of active infection within a
community, (2) infectivity given injection with a contaminated syringe, (3)
durability of the virus inside the syringe, and (4) the level of sharing among

IDUs (Needle et al 1998). These four factors can then be incorporated into a
mathematical formula which characterizes incidence rate. Therefore, the
incidence rate of HIV among IDUs is equal to the rate at which needles are

shared, multipfied by the probability of using an infected syringe, multiplied by
the rate at which needle/syringe exposure transmits the infection (Needle et al

1998). This model is useful in targeting the elements which have the most
significant impact on incident rates.

Metzger and colleagues note cumulative evidence that drug treatment
provides protection against HIV because drug abusers who enter and continue

treatment ultimately reduce their drug use and corresponding drug-related risk
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behaviors, such as the sharing of needles and sexual risk behaviors. Injection

drug users who enter substitution therapy early and remain in treatment have
lower HIV rates than those who do not enter treatment or drop out. Drug

treatment is a necessary component of a comprehensive prevention program
to assist at-risk populations in changing their behaviors and reducing their risk
for HIV. Clearly, drug users in treatment are less likely to inject drugs and

therefore, less likely to be exposed to H IV. Thus, there is a need to increase
the capacity of drug treatment for injection drug users (Needle et al. 1998).

Empirical data provides evidence for the complementary roles of

community-based outreach, needle/syringe exchange programs and drug

treatment in HIV prevention. Community based outreach provides access to
communities of drug users to prevent HIV. Needle and syringe exchange

programs provide sources for the referral of IDUs to drug treatment, which are
ideal mechanisms for delivering HIV prevention interventions. Retention in

drug treatment has proven to be a strong predictor of a positive outcome. Des
Jarlais and Friedman conclude from their assessment of HIV prevention

strategies that "the most important barrier to reducing HIV transmission among

IDU’s is not a lack of knowledge but the failure to implement effective
prevention programs in many parts of the world" (Needle et al 1998).
These studies indicate that prevention and science-based interventions
have been effective in reaching at-risk populations enabling them to reduce
their risk of acquiring HIV, Tuberculosis, Hepatitis and other sexually
transmitted diseases. These strategies underscore a need to anticipate the
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changing dynamics of the interrelated epidemics of drug abuse and HIV and

effectively respond to prevent the further spread of HIV and other related
diseases. Research indicates that the spread of disease in the drug-using

population and beyond is clearly preventable through effective harm and risk
reduction programs not supply side legal interventions (Needle et al 1998).

Therefore, based on the evidence gathered thus far, it is the
recommendation of this paper that the Russian Federation put into place the

following strategies to reduce the rate of HIV and related infectious diseases in
the injection drug use population:

1) Create an environment where the principles of Harm Reduction can not
only be put into practice, but do so without government interference.

=

=

=

Facilitate the establishment of community-based outreach

programs run by non-governmental organizations.
Police should allow IDUs to keep their injecting equipment and
not interfere with needle/syringe exchange programs.
Reduce the penalties for the possession and use of small
amounts of drugs to allow IDUs to participate in harm reduction
programs and to limit prison overcrowding.
Make the increase in the funding of and accessibility to drug
treatment centers a high governmental priority.
Legalize substitution therapy.
Provide anonymous HIV testing free of charge.

2) Encourage the establishment of community-based outreach programs
run primarily by non-governmental organizations.

=

Assemble and train a group of indigenous workers to engage
injection drug users within their own communities.
Establish a set of behavioral options and the means for
behavioral change to reduce the risk of HIV
Behavioral options should constitute a hierarchy which includes:
stop injecting drugs, if you cannot stop, do not share injection
equipment, if you must share, disinfect with bleach.
Disseminate information on safer drug use and bleach.
Disseminate information on safer sex and distribute condoms.
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Provide referrals to community-based programs for anonymous
HIV testing and counseling, drug treatment and other medical
and social services.
Peer driven intervention can reach a large and diverse
population of IDUs and is cost effective.

3) Expand the presence of needle/syringe exchange programs (NEP/SEP)

Encourage pharmacies to continue to make clean needles and
syringes available at modest cost to the injecting population.
Establish a wide variety of satellite exchange locations in
addition to local pharmacies, including fixed sites (drug treatment
centers, storefront clinics) and mobile vans. Satellites create
large transaction networks thereby extending coverage and
effectiveness.
Increase the hours of operation of fixed and mobile sites.
Vary the exchange ratio, e.g. two new needles/syringes for each
used one.
Provide information about safe injection techniques using bleach.
Provide referrals to drug treatment centers.
Provide information regarding safe sex practices and make
condoms available.
Provide ancillary services such as anonymous HIV testing,
counseling, crisis intervention and screening for TB, hepatitis,
and other sexually transmitted infections.

4) Establish network paradigms which represent social interconnections
between individuals and groups among the IDU population.
Shift the perspective from examining risk behaviors from an
individual perspective to examining them as behavioral
transactions between and among individuals and groups.
Focus on the context in which drugs are procured, prepared,
mixed and shared.
Focus on sexual risk-taking behaviors.
Network approach can be used to identify key players within the
injecting community. These individuals may then be recruited to
intervene with members of their IDU and sexual risk-taking

=

network.
Network characteristics will affect behavioral practices and
ultimately the risk of HIV transmission.
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5) Increase the public awareness of HIV and its risk factors.

=

Spread knowledge about HIV and reduce the general public’s
fears associated with contact with HIV positive individuals.
Strengthen the self-esteem of HIV infected individuals.
Employ the mass media to "de-mystify" HIV. Depict HIV infected
individuals as productive members of society.
Strengthen HIV information in schools, churches and other social

=

organizations.
Strengthen training about injection drug use and associated risk
factors among law enforcement personnel.
Encourage the development of organizations and support groups
for HIV infected individuals.
Provide access to anonymous HIV testing.

=

=

6) Address overcrowding and other risk factors for HIV and related
infectious diseases in the prison system.
Eliminate the use of "SIZO’s" or pre-trial detention centers for
accused illegal drug users.
Distribute information to drug users in prison about HIV and safe
injection practices.
Establish needle/syringe exchange centers in prisons, which
would also make bleach available for disinfection of injecting
equipment under controlled conditions.
Distribute information on safe-sex practices and make condoms
readily available.
Provide anonymous, voluntary HIV testing for prisoners.

7) Develop and implement public health strategies to control TB, hepatitis
A, B & C and sexually transmitted infections.

=

The risk of sexual transmission of HIV is increased in the
presence of syphilis or gonorrhea.
Individuals with hepatitis and/or tuberculosis will likely have
compromised immune systems which are less able to control
the effects of H IV.
High-risk centers should implement free and accessible
diagnostics of hepatitis A, B & C, TB and STI’s through the use
of community-based outreach, drug treatment centers, clinics
and NEP/SEPs.
High-risk centers should implement free, single-dose (where
applicable) treatment for these diseases through the use of

community-based outreach, drug treatment centers, clinics and
NEP/SEPs.
Provide vaccination against hepatitis A and hepatitis B free of
charge to all injection drug users.
Increase the coverage for Directly Observed Treatment, ShortCourse (DOTS) for tuberculosis with the goal of 100%

coverage.

8) Establish partnerships with groups in Finland and Norway to provide
assistance with the development and implementation of these
strategies.

Partnerships may provide advice and perhaps funding for
setting up and running community-based outreach programs,
drug treatment centers, clinics, NEP/SEPs, networks, etc.
Partnerships may provide advice and perhaps funding for
educational materials.
Partnerships may provide advice and perhaps funding for
diagnostic equipment and antibiotics.

(Needle, et al 1998)(Aavitsland 2001)
Clearly, the implementation of these strategies will not be easy and will
require a substantial monetary investment from the Russia Government in
addition to their support. However, there is ample evidence that the science-

based interventions listed above have been effective in reaching at-risk
populations, enabling them to reduce risk behaviors and consequently, their
risk of HIV infection. HIV transmission among the injection drug using

population is preventable.

VIII. Conclusions
The treaties of the 60’s, 70’s, 80’s and 90’s were designed to provide

enforceable international law with which to control the use of illegal drugs.

Early drafts relied primarily on supply side measures with a heavy emphasis

on drug control through law enforcement. Over numerous iterations,
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culminating with the 1998 Drug Summit, a gradual paradigm shift towards

demand side measures, which seek to reduce the harms associated with drug

abuse, can be noted. The demand side approach encompasses harm
reduction strategies, which include an emphasis on prevention, treatment,
rehabilitation and maintenance (after-care). Despite this ideological shift, most

countries continue to devote the majority of resources towards supply side

measures. This strategy flies in the face of mounting evidence that supply
side measures do little to quell drug abuse and may even contribute to the

harms associated with high risk behaviors such as injection drug use. The
connection between injection drug use and the spread of infectious diseases

such as HIV, TB, hepatitis and other sexually transmitted infections is clear.

On the other hand, empirical data continues to support the efficacy of harm
reduction strategies in limiting the transmission of infectious diseases

associated with injection drug use.

Thus, world wide drug use continues to increase along with the
associated harms. And no where is this calamity more evident than in the
Russian Federation. Despite the stiffening of penalties under the 1998

Russian Law on Narcotics and Psychotropic Substances, drug abuse
continues to spiral out of control. Socioeconomic factors associated with the

break up of the Soviet Union in 1991 have given rise to an epidemic of
injection drug use. The rise in injection drug use has paralleled an equally
dramatic rise in the incidence of HIV/AIDS. Nationally, 54% of HIV infections

are transmitted through injection drug use, with figures as high as 90% in
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localized areas. Concomitant rises in the incidence of associated infectious
disease such as TB, hepatitis A, B & C, and sexually transmitted infections

have jumped on board.
The situation in Russia is in clear contrast to that of neighboring Finland
and Norway. While publicly reinforcing the ideals of a "drug free society", both
Finland and Norway have been relatively quick to embrace the components of

harm reduction. While maintaining strict drug laws, the emphasis of both

governments has focused on demand side strategies which seek to limit the
harms associated with drug abuse. Prevention strategies, accessible

treatment for drug use and infectious diseases, rehabilitation and maintenance
have been the focal point of the national public health strategies in these two
countries. The result has been low and stable incidence rates of HIV, TB

hepatitis A, B & C and other sexually transmitted infections.

The national epidemic of injection drug use will surely wrought
devastation on the fledgling capitalist economy of Russia. Centered on the 16

24 age groups, the effects of this outbreak will surely be felt for years to

come. Another concern is that the bourgeoning epidemics of drug abuse and
related infectious diseases in Russia will spill over into neighboring countries
such as Finland and Norway. Thus, while it is apparent that the Russian
Federation needs to develop a public health approach which embraces the

strategies outlined in this paper, it behooves the countries of Finland and

Norway to assist in any way possible.
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The grace period for the development of an action plan has come and

gone. The time is now for representatives from these three countries to form a
tri-national public health committee to address this problem. The transmission

of HIV and related infectious diseases through injection drug use is clearly

preventable, but only if the tenets of harm reduction are embraced on a
national level and in a timely fashion.
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